DE69615411T2 - Verfahren zur Herstellung von Polynucleotiden mit erwünschten Eigenschaften mittels wiederholter Selektion und Rekombination - Google Patents
Verfahren zur Herstellung von Polynucleotiden mit erwünschten Eigenschaften mittels wiederholter Selektion und RekombinationInfo
- Publication number
- DE69615411T2 DE69615411T2 DE69615411T DE69615411T DE69615411T2 DE 69615411 T2 DE69615411 T2 DE 69615411T2 DE 69615411 T DE69615411 T DE 69615411T DE 69615411 T DE69615411 T DE 69615411T DE 69615411 T2 DE69615411 T2 DE 69615411T2
- Authority
- DE
- Germany
- Prior art keywords
- sequence
- recombination
- polynucleotide
- dna
- sequences
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 102000040430 polynucleotide Human genes 0.000 title claims abstract description 277
- 108091033319 polynucleotide Proteins 0.000 title claims abstract description 277
- 239000002157 polynucleotide Substances 0.000 title claims abstract description 277
- 238000000034 method Methods 0.000 title claims abstract description 213
- 230000008569 process Effects 0.000 title claims description 21
- 230000006798 recombination Effects 0.000 title description 246
- 238000005215 recombination Methods 0.000 title description 243
- 238000002360 preparation method Methods 0.000 title description 11
- 238000012216 screening Methods 0.000 claims abstract description 58
- 108090000623 proteins and genes Proteins 0.000 claims description 329
- 241000894007 species Species 0.000 claims description 73
- 230000014509 gene expression Effects 0.000 claims description 36
- 102000004190 Enzymes Human genes 0.000 claims description 31
- 108090000790 Enzymes Proteins 0.000 claims description 31
- 230000001976 improved effect Effects 0.000 claims description 30
- 230000001580 bacterial effect Effects 0.000 claims description 24
- 230000029087 digestion Effects 0.000 claims description 23
- 238000004153 renaturation Methods 0.000 claims description 19
- DJHGAFSJWGLOIV-UHFFFAOYSA-K Arsenate3- Chemical compound [O-][As]([O-])([O-])=O DJHGAFSJWGLOIV-UHFFFAOYSA-K 0.000 claims description 17
- 229940000489 arsenate Drugs 0.000 claims description 17
- 230000003115 biocidal effect Effects 0.000 claims description 17
- QSHDDOUJBYECFT-UHFFFAOYSA-N mercury Chemical compound [Hg] QSHDDOUJBYECFT-UHFFFAOYSA-N 0.000 claims description 8
- 229910052753 mercury Inorganic materials 0.000 claims description 8
- 238000004925 denaturation Methods 0.000 claims description 7
- 239000003814 drug Substances 0.000 claims description 7
- 229940079593 drug Drugs 0.000 claims description 7
- 230000036425 denaturation Effects 0.000 claims description 6
- 102000007260 Deoxyribonuclease I Human genes 0.000 claims description 5
- 108010008532 Deoxyribonuclease I Proteins 0.000 claims description 5
- 239000003242 anti bacterial agent Substances 0.000 claims description 5
- 230000037353 metabolic pathway Effects 0.000 claims description 5
- 229930000044 secondary metabolite Natural products 0.000 claims description 5
- 241001465754 Metazoa Species 0.000 claims description 3
- 229910001385 heavy metal Inorganic materials 0.000 claims 1
- 231100000331 toxic Toxicity 0.000 claims 1
- 230000002588 toxic effect Effects 0.000 claims 1
- 239000012634 fragment Substances 0.000 abstract description 216
- 150000007523 nucleic acids Chemical group 0.000 abstract description 169
- 210000004027 cell Anatomy 0.000 description 322
- 239000013612 plasmid Substances 0.000 description 198
- 108020004414 DNA Proteins 0.000 description 191
- 230000035772 mutation Effects 0.000 description 134
- 239000013598 vector Substances 0.000 description 133
- 239000013615 primer Substances 0.000 description 113
- 102000004169 proteins and genes Human genes 0.000 description 94
- 239000000047 product Substances 0.000 description 91
- 235000018102 proteins Nutrition 0.000 description 91
- 108010043121 Green Fluorescent Proteins Proteins 0.000 description 73
- 102000004144 Green Fluorescent Proteins Human genes 0.000 description 71
- 239000005090 green fluorescent protein Substances 0.000 description 71
- 241000588724 Escherichia coli Species 0.000 description 70
- 238000006243 chemical reaction Methods 0.000 description 70
- 239000000203 mixture Substances 0.000 description 70
- 102000039446 nucleic acids Human genes 0.000 description 67
- 108020004707 nucleic acids Proteins 0.000 description 67
- 108091034117 Oligonucleotide Proteins 0.000 description 58
- 239000000758 substrate Substances 0.000 description 52
- 229960004261 cefotaxime Drugs 0.000 description 47
- AZZMGZXNTDTSME-JUZDKLSSSA-M cefotaxime sodium Chemical compound [Na+].N([C@@H]1C(N2C(=C(COC(C)=O)CS[C@@H]21)C([O-])=O)=O)C(=O)\C(=N/OC)C1=CSC(N)=N1 AZZMGZXNTDTSME-JUZDKLSSSA-M 0.000 description 47
- 108090000765 processed proteins & peptides Proteins 0.000 description 47
- 230000003321 amplification Effects 0.000 description 46
- 238000003199 nucleic acid amplification method Methods 0.000 description 46
- 238000000338 in vitro Methods 0.000 description 45
- 238000001727 in vivo Methods 0.000 description 45
- 230000001965 increasing effect Effects 0.000 description 42
- 235000001014 amino acid Nutrition 0.000 description 41
- 241000700605 Viruses Species 0.000 description 39
- 108091028043 Nucleic acid sequence Proteins 0.000 description 38
- 230000027455 binding Effects 0.000 description 38
- 238000002703 mutagenesis Methods 0.000 description 38
- 231100000350 mutagenesis Toxicity 0.000 description 38
- 230000001939 inductive effect Effects 0.000 description 37
- 108010047041 Complementarity Determining Regions Proteins 0.000 description 36
- 229940024606 amino acid Drugs 0.000 description 35
- 150000001413 amino acids Chemical class 0.000 description 35
- 238000004520 electroporation Methods 0.000 description 34
- 238000012546 transfer Methods 0.000 description 33
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 30
- JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 30
- 102000004196 processed proteins & peptides Human genes 0.000 description 29
- 239000002773 nucleotide Substances 0.000 description 26
- 125000003729 nucleotide group Chemical group 0.000 description 26
- 238000007792 addition Methods 0.000 description 25
- 102000053602 DNA Human genes 0.000 description 23
- 239000000654 additive Substances 0.000 description 23
- 229920001184 polypeptide Polymers 0.000 description 23
- 238000003780 insertion Methods 0.000 description 22
- 230000037431 insertion Effects 0.000 description 22
- 108020004705 Codon Proteins 0.000 description 21
- 238000010367 cloning Methods 0.000 description 21
- 238000002744 homologous recombination Methods 0.000 description 21
- 230000006801 homologous recombination Effects 0.000 description 21
- 101150079601 recA gene Proteins 0.000 description 21
- 241000894006 Bacteria Species 0.000 description 20
- 108090000204 Dipeptidase 1 Proteins 0.000 description 20
- 230000000996 additive effect Effects 0.000 description 19
- 230000021615 conjugation Effects 0.000 description 19
- TWRXJAOTZQYOKJ-UHFFFAOYSA-L Magnesium chloride Chemical compound [Mg+2].[Cl-].[Cl-] TWRXJAOTZQYOKJ-UHFFFAOYSA-L 0.000 description 18
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 18
- 108010006785 Taq Polymerase Proteins 0.000 description 18
- 239000000499 gel Substances 0.000 description 18
- 239000003471 mutagenic agent Substances 0.000 description 18
- 108091032973 (ribonucleotides)n+m Proteins 0.000 description 17
- 239000003550 marker Substances 0.000 description 17
- 108091008146 restriction endonucleases Proteins 0.000 description 17
- 230000001568 sexual effect Effects 0.000 description 17
- 230000003612 virological effect Effects 0.000 description 17
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 16
- 102000018120 Recombinases Human genes 0.000 description 16
- 108010091086 Recombinases Proteins 0.000 description 16
- 208000003028 Stuttering Diseases 0.000 description 16
- 239000011543 agarose gel Substances 0.000 description 16
- 125000003275 alpha amino acid group Chemical group 0.000 description 16
- 230000015572 biosynthetic process Effects 0.000 description 16
- 210000000349 chromosome Anatomy 0.000 description 16
- 230000006872 improvement Effects 0.000 description 16
- 239000003795 chemical substances by application Substances 0.000 description 15
- 230000036961 partial effect Effects 0.000 description 15
- 101150049515 bla gene Proteins 0.000 description 14
- 102000005962 receptors Human genes 0.000 description 14
- 108020003175 receptors Proteins 0.000 description 14
- 102200096993 rs199473501 Human genes 0.000 description 13
- 101000740462 Escherichia coli Beta-lactamase TEM Proteins 0.000 description 12
- 102220501268 N-acetyltransferase 8_E104K_mutation Human genes 0.000 description 12
- 238000012219 cassette mutagenesis Methods 0.000 description 12
- 230000000694 effects Effects 0.000 description 12
- 230000012010 growth Effects 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 12
- 238000002844 melting Methods 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 101150069263 tra gene Proteins 0.000 description 12
- 108700010070 Codon Usage Proteins 0.000 description 11
- 229920004890 Triton X-100 Polymers 0.000 description 11
- 238000000137 annealing Methods 0.000 description 11
- 230000002759 chromosomal effect Effects 0.000 description 11
- 239000013604 expression vector Substances 0.000 description 11
- 238000013467 fragmentation Methods 0.000 description 11
- 238000006062 fragmentation reaction Methods 0.000 description 11
- 230000006870 function Effects 0.000 description 11
- 239000013600 plasmid vector Substances 0.000 description 11
- 108700028369 Alleles Proteins 0.000 description 10
- 108091026890 Coding region Proteins 0.000 description 10
- 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 10
- 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 10
- 239000002202 Polyethylene glycol Substances 0.000 description 10
- 239000013504 Triton X-100 Substances 0.000 description 10
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 description 10
- 229960000723 ampicillin Drugs 0.000 description 10
- AVKUERGKIZMTKX-NJBDSQKTSA-N ampicillin Chemical compound C1([C@@H](N)C(=O)N[C@H]2[C@H]3SC([C@@H](N3C2=O)C(O)=O)(C)C)=CC=CC=C1 AVKUERGKIZMTKX-NJBDSQKTSA-N 0.000 description 10
- 238000004458 analytical method Methods 0.000 description 10
- 239000000427 antigen Substances 0.000 description 10
- 108091007433 antigens Proteins 0.000 description 10
- 102000036639 antigens Human genes 0.000 description 10
- 108010002833 beta-lactamase TEM-1 Proteins 0.000 description 10
- 230000000295 complement effect Effects 0.000 description 10
- 238000009396 hybridization Methods 0.000 description 10
- 230000007935 neutral effect Effects 0.000 description 10
- 229920001223 polyethylene glycol Polymers 0.000 description 10
- 230000010076 replication Effects 0.000 description 10
- 239000000126 substance Substances 0.000 description 10
- 101150066002 GFP gene Proteins 0.000 description 9
- 108020004682 Single-Stranded DNA Proteins 0.000 description 9
- 210000004978 chinese hamster ovary cell Anatomy 0.000 description 9
- 238000001784 detoxification Methods 0.000 description 9
- 239000003446 ligand Substances 0.000 description 9
- 229910001629 magnesium chloride Inorganic materials 0.000 description 9
- 230000037432 silent mutation Effects 0.000 description 9
- 239000011780 sodium chloride Substances 0.000 description 9
- 229920001817 Agar Polymers 0.000 description 8
- 108010017826 DNA Polymerase I Proteins 0.000 description 8
- 102000004594 DNA Polymerase I Human genes 0.000 description 8
- 238000002965 ELISA Methods 0.000 description 8
- 108060002716 Exonuclease Proteins 0.000 description 8
- 101000919370 Homo sapiens Cone-rod homeobox protein Proteins 0.000 description 8
- 101001104102 Homo sapiens X-linked retinitis pigmentosa GTPase regulator Proteins 0.000 description 8
- 108060003951 Immunoglobulin Proteins 0.000 description 8
- 238000012408 PCR amplification Methods 0.000 description 8
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 8
- 102100040092 X-linked retinitis pigmentosa GTPase regulator Human genes 0.000 description 8
- 239000008272 agar Substances 0.000 description 8
- 101150087698 alpha gene Proteins 0.000 description 8
- 102000006635 beta-lactamase Human genes 0.000 description 8
- 239000003599 detergent Substances 0.000 description 8
- 102000013165 exonuclease Human genes 0.000 description 8
- 238000002474 experimental method Methods 0.000 description 8
- 230000002068 genetic effect Effects 0.000 description 8
- 102000018358 immunoglobulin Human genes 0.000 description 8
- 208000015181 infectious disease Diseases 0.000 description 8
- 210000004962 mammalian cell Anatomy 0.000 description 8
- 231100000219 mutagenic Toxicity 0.000 description 8
- 230000003505 mutagenic effect Effects 0.000 description 8
- -1 polymerases Proteins 0.000 description 8
- 230000001915 proofreading effect Effects 0.000 description 8
- 150000003839 salts Chemical class 0.000 description 8
- 238000006467 substitution reaction Methods 0.000 description 8
- 239000013603 viral vector Substances 0.000 description 8
- 108010021466 Mutant Proteins Proteins 0.000 description 7
- 102000008300 Mutant Proteins Human genes 0.000 description 7
- OKIZCWYLBDKLSU-UHFFFAOYSA-M N,N,N-Trimethylmethanaminium chloride Chemical compound [Cl-].C[N+](C)(C)C OKIZCWYLBDKLSU-UHFFFAOYSA-M 0.000 description 7
- 101710163270 Nuclease Proteins 0.000 description 7
- 239000004098 Tetracycline Substances 0.000 description 7
- 230000008901 benefit Effects 0.000 description 7
- 238000010276 construction Methods 0.000 description 7
- 230000002401 inhibitory effect Effects 0.000 description 7
- 230000003993 interaction Effects 0.000 description 7
- 238000012986 modification Methods 0.000 description 7
- 230000004048 modification Effects 0.000 description 7
- 230000037361 pathway Effects 0.000 description 7
- 229960002180 tetracycline Drugs 0.000 description 7
- 229930101283 tetracycline Natural products 0.000 description 7
- 235000019364 tetracycline Nutrition 0.000 description 7
- 150000003522 tetracyclines Chemical class 0.000 description 7
- LZZYPRNAOMGNLH-UHFFFAOYSA-M Cetrimonium bromide Chemical compound [Br-].CCCCCCCCCCCCCCCC[N+](C)(C)C LZZYPRNAOMGNLH-UHFFFAOYSA-M 0.000 description 6
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 6
- 238000001712 DNA sequencing Methods 0.000 description 6
- 108700024394 Exon Proteins 0.000 description 6
- 241000283973 Oryctolagus cuniculus Species 0.000 description 6
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 125000002091 cationic group Chemical group 0.000 description 6
- 230000008859 change Effects 0.000 description 6
- 239000002299 complementary DNA Substances 0.000 description 6
- 238000005520 cutting process Methods 0.000 description 6
- 230000005284 excitation Effects 0.000 description 6
- 238000001943 fluorescence-activated cell sorting Methods 0.000 description 6
- 229920002521 macromolecule Polymers 0.000 description 6
- 230000008018 melting Effects 0.000 description 6
- 239000002953 phosphate buffered saline Substances 0.000 description 6
- 238000011160 research Methods 0.000 description 6
- 238000013518 transcription Methods 0.000 description 6
- 230000035897 transcription Effects 0.000 description 6
- 108091028732 Concatemer Proteins 0.000 description 5
- 108010054017 Granulocyte Colony-Stimulating Factor Receptors Proteins 0.000 description 5
- 102100039622 Granulocyte colony-stimulating factor receptor Human genes 0.000 description 5
- 238000003314 affinity selection Methods 0.000 description 5
- 125000000539 amino acid group Chemical group 0.000 description 5
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 5
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 5
- 238000003556 assay Methods 0.000 description 5
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 5
- 230000004071 biological effect Effects 0.000 description 5
- 238000004422 calculation algorithm Methods 0.000 description 5
- 150000001875 compounds Chemical class 0.000 description 5
- 238000001514 detection method Methods 0.000 description 5
- 238000005516 engineering process Methods 0.000 description 5
- 238000001415 gene therapy Methods 0.000 description 5
- 230000005847 immunogenicity Effects 0.000 description 5
- 210000003000 inclusion body Anatomy 0.000 description 5
- 238000011534 incubation Methods 0.000 description 5
- 230000003834 intracellular effect Effects 0.000 description 5
- 230000001404 mediated effect Effects 0.000 description 5
- 238000002156 mixing Methods 0.000 description 5
- 238000005457 optimization Methods 0.000 description 5
- 230000000644 propagated effect Effects 0.000 description 5
- 102220283250 rs772349818 Human genes 0.000 description 5
- 238000012163 sequencing technique Methods 0.000 description 5
- 238000002741 site-directed mutagenesis Methods 0.000 description 5
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 5
- 238000001890 transfection Methods 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 229940035893 uracil Drugs 0.000 description 5
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 5
- OPIFSICVWOWJMJ-AEOCFKNESA-N 5-bromo-4-chloro-3-indolyl beta-D-galactoside Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1OC1=CNC2=CC=C(Br)C(Cl)=C12 OPIFSICVWOWJMJ-AEOCFKNESA-N 0.000 description 4
- 239000004475 Arginine Substances 0.000 description 4
- 102000012410 DNA Ligases Human genes 0.000 description 4
- 108010061982 DNA Ligases Proteins 0.000 description 4
- 238000007702 DNA assembly Methods 0.000 description 4
- 108010053770 Deoxyribonucleases Proteins 0.000 description 4
- 102000016911 Deoxyribonucleases Human genes 0.000 description 4
- 206010059866 Drug resistance Diseases 0.000 description 4
- 241000196324 Embryophyta Species 0.000 description 4
- 241001524679 Escherichia virus M13 Species 0.000 description 4
- 241000724791 Filamentous phage Species 0.000 description 4
- NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 4
- 108010002747 Pfu DNA polymerase Proteins 0.000 description 4
- 102100030919 Phosphatidylcholine:ceramide cholinephosphotransferase 1 Human genes 0.000 description 4
- 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 4
- 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 4
- 238000012300 Sequence Analysis Methods 0.000 description 4
- 108700005078 Synthetic Genes Proteins 0.000 description 4
- 150000007513 acids Chemical class 0.000 description 4
- 230000004913 activation Effects 0.000 description 4
- 230000002776 aggregation Effects 0.000 description 4
- 238000004220 aggregation Methods 0.000 description 4
- 238000001816 cooling Methods 0.000 description 4
- 238000012217 deletion Methods 0.000 description 4
- 230000037430 deletion Effects 0.000 description 4
- 238000010586 diagram Methods 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- XJWSAJYUBXQQDR-UHFFFAOYSA-M dodecyltrimethylammonium bromide Chemical compound [Br-].CCCCCCCCCCCC[N+](C)(C)C XJWSAJYUBXQQDR-UHFFFAOYSA-M 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 4
- 108020004999 messenger RNA Proteins 0.000 description 4
- 231100000707 mutagenic chemical Toxicity 0.000 description 4
- 238000004091 panning Methods 0.000 description 4
- 239000008188 pellet Substances 0.000 description 4
- 238000002823 phage display Methods 0.000 description 4
- 230000004962 physiological condition Effects 0.000 description 4
- 238000007747 plating Methods 0.000 description 4
- 238000000746 purification Methods 0.000 description 4
- 239000007787 solid Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000003786 synthesis reaction Methods 0.000 description 4
- 241001515965 unidentified phage Species 0.000 description 4
- NFGXHKASABOEEW-UHFFFAOYSA-N 1-methylethyl 11-methoxy-3,7,11-trimethyl-2,4-dodecadienoate Chemical compound COC(C)(C)CCCC(C)CC=CC(C)=CC(=O)OC(C)C NFGXHKASABOEEW-UHFFFAOYSA-N 0.000 description 3
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 3
- 108010067770 Endopeptidase K Proteins 0.000 description 3
- 108090000144 Human Proteins Proteins 0.000 description 3
- 102000003839 Human Proteins Human genes 0.000 description 3
- 108700005091 Immunoglobulin Genes Proteins 0.000 description 3
- 108091092195 Intron Proteins 0.000 description 3
- 101001033286 Mus musculus Interleukin-1 beta Proteins 0.000 description 3
- 102000011931 Nucleoproteins Human genes 0.000 description 3
- 108010061100 Nucleoproteins Proteins 0.000 description 3
- 239000012807 PCR reagent Substances 0.000 description 3
- 108010055016 Rec A Recombinases Proteins 0.000 description 3
- 102000001218 Rec A Recombinases Human genes 0.000 description 3
- 108091005971 Wild-type GFP Proteins 0.000 description 3
- 238000013459 approach Methods 0.000 description 3
- ODKSFYDXXFIFQN-UHFFFAOYSA-N arginine Natural products OC(=O)C(N)CCCNC(N)=N ODKSFYDXXFIFQN-UHFFFAOYSA-N 0.000 description 3
- 238000000429 assembly Methods 0.000 description 3
- 230000000712 assembly Effects 0.000 description 3
- 230000009286 beneficial effect Effects 0.000 description 3
- 230000033228 biological regulation Effects 0.000 description 3
- 238000009395 breeding Methods 0.000 description 3
- 230000001488 breeding effect Effects 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 235000011089 carbon dioxide Nutrition 0.000 description 3
- 150000001768 cations Chemical class 0.000 description 3
- 238000011161 development Methods 0.000 description 3
- 230000018109 developmental process Effects 0.000 description 3
- 108010048367 enhanced green fluorescent protein Proteins 0.000 description 3
- 210000003527 eukaryotic cell Anatomy 0.000 description 3
- 239000000284 extract Substances 0.000 description 3
- 238000001506 fluorescence spectroscopy Methods 0.000 description 3
- 230000002209 hydrophobic effect Effects 0.000 description 3
- 125000001165 hydrophobic group Chemical group 0.000 description 3
- 230000010354 integration Effects 0.000 description 3
- 238000005342 ion exchange Methods 0.000 description 3
- 238000002955 isolation Methods 0.000 description 3
- 230000000670 limiting effect Effects 0.000 description 3
- 238000001638 lipofection Methods 0.000 description 3
- 239000007788 liquid Substances 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000000178 monomer Substances 0.000 description 3
- 238000003752 polymerase chain reaction Methods 0.000 description 3
- 230000037452 priming Effects 0.000 description 3
- 230000001902 propagating effect Effects 0.000 description 3
- 238000002708 random mutagenesis Methods 0.000 description 3
- 238000011084 recovery Methods 0.000 description 3
- 230000003362 replicative effect Effects 0.000 description 3
- 239000011347 resin Substances 0.000 description 3
- 229920005989 resin Polymers 0.000 description 3
- 150000003384 small molecules Chemical class 0.000 description 3
- 230000009870 specific binding Effects 0.000 description 3
- 239000007858 starting material Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 210000001519 tissue Anatomy 0.000 description 3
- 210000002845 virion Anatomy 0.000 description 3
- 210000005253 yeast cell Anatomy 0.000 description 3
- AXAVXPMQTGXXJZ-UHFFFAOYSA-N 2-aminoacetic acid;2-amino-2-(hydroxymethyl)propane-1,3-diol Chemical compound NCC(O)=O.OCC(N)(CO)CO AXAVXPMQTGXXJZ-UHFFFAOYSA-N 0.000 description 2
- 241000242764 Aequorea victoria Species 0.000 description 2
- 108010000239 Aequorin Proteins 0.000 description 2
- 244000153158 Ammi visnaga Species 0.000 description 2
- 235000010585 Ammi visnaga Nutrition 0.000 description 2
- 108090000994 Catalytic RNA Proteins 0.000 description 2
- 102000053642 Catalytic RNA Human genes 0.000 description 2
- 108020004638 Circular DNA Proteins 0.000 description 2
- 108020004635 Complementary DNA Proteins 0.000 description 2
- 241000699802 Cricetulus griseus Species 0.000 description 2
- MIKUYHXYGGJMLM-GIMIYPNGSA-N Crotonoside Natural products C1=NC2=C(N)NC(=O)N=C2N1[C@H]1O[C@@H](CO)[C@H](O)[C@@H]1O MIKUYHXYGGJMLM-GIMIYPNGSA-N 0.000 description 2
- NYHBQMYGNKIUIF-UHFFFAOYSA-N D-guanosine Natural products C1=2NC(N)=NC(=O)C=2N=CN1C1OC(CO)C(O)C1O NYHBQMYGNKIUIF-UHFFFAOYSA-N 0.000 description 2
- 239000003155 DNA primer Substances 0.000 description 2
- 230000006820 DNA synthesis Effects 0.000 description 2
- 102000052510 DNA-Binding Proteins Human genes 0.000 description 2
- 101710096438 DNA-binding protein Proteins 0.000 description 2
- 241000701832 Enterobacteria phage T3 Species 0.000 description 2
- 241000206602 Eukaryota Species 0.000 description 2
- 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- 101710114810 Glycoprotein Proteins 0.000 description 2
- ZRALSGWEFCBTJO-UHFFFAOYSA-N Guanidine Chemical compound NC(N)=N ZRALSGWEFCBTJO-UHFFFAOYSA-N 0.000 description 2
- 101100356020 Haemophilus influenzae (strain ATCC 51907 / DSM 11121 / KW20 / Rd) recA gene Proteins 0.000 description 2
- 101000746364 Homo sapiens Granulocyte colony-stimulating factor receptor Proteins 0.000 description 2
- 101001033249 Homo sapiens Interleukin-1 beta Proteins 0.000 description 2
- OAKJQQAXSVQMHS-UHFFFAOYSA-N Hydrazine Chemical compound NN OAKJQQAXSVQMHS-UHFFFAOYSA-N 0.000 description 2
- 108010067060 Immunoglobulin Variable Region Proteins 0.000 description 2
- 102100034343 Integrase Human genes 0.000 description 2
- 108020005210 Integrons Proteins 0.000 description 2
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 description 2
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 description 2
- 108060001084 Luciferase Proteins 0.000 description 2
- 239000005089 Luciferase Substances 0.000 description 2
- FUSGACRLAFQQRL-UHFFFAOYSA-N N-Ethyl-N-nitrosourea Chemical compound CCN(N=O)C(N)=O FUSGACRLAFQQRL-UHFFFAOYSA-N 0.000 description 2
- YHIPILPTUVMWQT-UHFFFAOYSA-N Oplophorus luciferin Chemical compound C1=CC(O)=CC=C1CC(C(N1C=C(N2)C=3C=CC(O)=CC=3)=O)=NC1=C2CC1=CC=CC=C1 YHIPILPTUVMWQT-UHFFFAOYSA-N 0.000 description 2
- 241000702244 Orthoreovirus Species 0.000 description 2
- 108010021757 Polynucleotide 5'-Hydroxyl-Kinase Proteins 0.000 description 2
- 102000008422 Polynucleotide 5'-hydroxyl-kinase Human genes 0.000 description 2
- 108020004511 Recombinant DNA Proteins 0.000 description 2
- 102000004389 Ribonucleoproteins Human genes 0.000 description 2
- 108010081734 Ribonucleoproteins Proteins 0.000 description 2
- 101100264226 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) XRN1 gene Proteins 0.000 description 2
- BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 2
- 101710167605 Spike glycoprotein Proteins 0.000 description 2
- IQFYYKKMVGJFEH-XLPZGREQSA-N Thymidine Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](CO)[C@@H](O)C1 IQFYYKKMVGJFEH-XLPZGREQSA-N 0.000 description 2
- 229910052770 Uranium Inorganic materials 0.000 description 2
- 244000301083 Ustilago maydis Species 0.000 description 2
- 235000015919 Ustilago maydis Nutrition 0.000 description 2
- 108010067390 Viral Proteins Proteins 0.000 description 2
- 238000009825 accumulation Methods 0.000 description 2
- DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
- 238000000246 agarose gel electrophoresis Methods 0.000 description 2
- 229940088710 antibiotic agent Drugs 0.000 description 2
- 238000010804 cDNA synthesis Methods 0.000 description 2
- 230000003197 catalytic effect Effects 0.000 description 2
- 230000001413 cellular effect Effects 0.000 description 2
- 238000005119 centrifugation Methods 0.000 description 2
- 239000007795 chemical reaction product Substances 0.000 description 2
- 239000013611 chromosomal DNA Substances 0.000 description 2
- 230000002860 competitive effect Effects 0.000 description 2
- 239000002131 composite material Substances 0.000 description 2
- OPTASPLRGRRNAP-UHFFFAOYSA-N cytosine Chemical compound NC=1C=CNC(=O)N=1 OPTASPLRGRRNAP-UHFFFAOYSA-N 0.000 description 2
- SUYVUBYJARFZHO-RRKCRQDMSA-N dATP Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-RRKCRQDMSA-N 0.000 description 2
- SUYVUBYJARFZHO-UHFFFAOYSA-N dATP Natural products C1=NC=2C(N)=NC=NC=2N1C1CC(O)C(COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 SUYVUBYJARFZHO-UHFFFAOYSA-N 0.000 description 2
- RGWHQCVHVJXOKC-SHYZEUOFSA-J dCTP(4-) Chemical compound O=C1N=C(N)C=CN1[C@@H]1O[C@H](COP([O-])(=O)OP([O-])(=O)OP([O-])([O-])=O)[C@@H](O)C1 RGWHQCVHVJXOKC-SHYZEUOFSA-J 0.000 description 2
- HAAZLUGHYHWQIW-KVQBGUIXSA-N dGTP Chemical compound C1=NC=2C(=O)NC(N)=NC=2N1[C@H]1C[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 HAAZLUGHYHWQIW-KVQBGUIXSA-N 0.000 description 2
- NHVNXKFIZYSCEB-XLPZGREQSA-N dTTP Chemical compound O=C1NC(=O)C(C)=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)C1 NHVNXKFIZYSCEB-XLPZGREQSA-N 0.000 description 2
- 230000002950 deficient Effects 0.000 description 2
- 229960000633 dextran sulfate Drugs 0.000 description 2
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 239000012467 final product Substances 0.000 description 2
- 210000004602 germ cell Anatomy 0.000 description 2
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 2
- 229910052737 gold Inorganic materials 0.000 description 2
- 239000010931 gold Substances 0.000 description 2
- 229940029575 guanosine Drugs 0.000 description 2
- 230000036541 health Effects 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- 230000001900 immune effect Effects 0.000 description 2
- 230000002163 immunogen Effects 0.000 description 2
- 238000010348 incorporation Methods 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- 229960000310 isoleucine Drugs 0.000 description 2
- 238000009630 liquid culture Methods 0.000 description 2
- 230000001320 lysogenic effect Effects 0.000 description 2
- 230000002101 lytic effect Effects 0.000 description 2
- 238000013507 mapping Methods 0.000 description 2
- 239000002609 medium Substances 0.000 description 2
- BDAGIHXWWSANSR-UHFFFAOYSA-N methanoic acid Natural products OC=O BDAGIHXWWSANSR-UHFFFAOYSA-N 0.000 description 2
- 235000013336 milk Nutrition 0.000 description 2
- 239000008267 milk Substances 0.000 description 2
- 210000004080 milk Anatomy 0.000 description 2
- 238000010369 molecular cloning Methods 0.000 description 2
- 230000036438 mutation frequency Effects 0.000 description 2
- 229910052757 nitrogen Inorganic materials 0.000 description 2
- OSTGTTZJOCZWJG-UHFFFAOYSA-N nitrosourea Chemical compound NC(=O)N=NO OSTGTTZJOCZWJG-UHFFFAOYSA-N 0.000 description 2
- 239000002777 nucleoside Substances 0.000 description 2
- 230000003287 optical effect Effects 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 229910052698 phosphorus Inorganic materials 0.000 description 2
- 229920000642 polymer Polymers 0.000 description 2
- 238000006116 polymerization reaction Methods 0.000 description 2
- 210000002729 polyribosome Anatomy 0.000 description 2
- 229920000136 polysorbate Polymers 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 230000003334 potential effect Effects 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 239000002243 precursor Substances 0.000 description 2
- 125000002924 primary amino group Chemical group [H]N([H])* 0.000 description 2
- 238000012545 processing Methods 0.000 description 2
- 210000001236 prokaryotic cell Anatomy 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 230000012846 protein folding Effects 0.000 description 2
- 230000005855 radiation Effects 0.000 description 2
- 230000002829 reductive effect Effects 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 230000000717 retained effect Effects 0.000 description 2
- 108091092562 ribozyme Proteins 0.000 description 2
- 102220302430 rs1030446889 Human genes 0.000 description 2
- 102220321637 rs377730553 Human genes 0.000 description 2
- 102220156356 rs886046630 Human genes 0.000 description 2
- 238000007423 screening assay Methods 0.000 description 2
- 239000006152 selective media Substances 0.000 description 2
- 230000014639 sexual reproduction Effects 0.000 description 2
- 229910052709 silver Inorganic materials 0.000 description 2
- 239000004332 silver Substances 0.000 description 2
- 125000006850 spacer group Chemical group 0.000 description 2
- 230000002194 synthesizing effect Effects 0.000 description 2
- 230000002103 transcriptional effect Effects 0.000 description 2
- 238000010361 transduction Methods 0.000 description 2
- 230000026683 transduction Effects 0.000 description 2
- 230000007704 transition Effects 0.000 description 2
- 238000013519 translation Methods 0.000 description 2
- 241001529453 unidentified herpesvirus Species 0.000 description 2
- 241001430294 unidentified retrovirus Species 0.000 description 2
- 238000011144 upstream manufacturing Methods 0.000 description 2
- 239000004474 valine Substances 0.000 description 2
- 230000000007 visual effect Effects 0.000 description 2
- MTCFGRXMJLQNBG-REOHCLBHSA-N (2S)-2-Amino-3-hydroxypropansäure Chemical compound OC[C@H](N)C(O)=O MTCFGRXMJLQNBG-REOHCLBHSA-N 0.000 description 1
- HKZAAJSTFUZYTO-LURJTMIESA-N (2s)-2-[[2-[[2-[[2-[(2-aminoacetyl)amino]acetyl]amino]acetyl]amino]acetyl]amino]-3-hydroxypropanoic acid Chemical compound NCC(=O)NCC(=O)NCC(=O)NCC(=O)N[C@@H](CO)C(O)=O HKZAAJSTFUZYTO-LURJTMIESA-N 0.000 description 1
- BEJKOYIMCGMNRB-GRHHLOCNSA-N (2s)-2-amino-3-(4-hydroxyphenyl)propanoic acid;(2s)-2-amino-3-phenylpropanoic acid Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1.OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 BEJKOYIMCGMNRB-GRHHLOCNSA-N 0.000 description 1
- IVLXQGJVBGMLRR-UHFFFAOYSA-N 2-aminoacetic acid;hydron;chloride Chemical compound Cl.NCC(O)=O IVLXQGJVBGMLRR-UHFFFAOYSA-N 0.000 description 1
- MWBWWFOAEOYUST-UHFFFAOYSA-N 2-aminopurine Chemical compound NC1=NC=C2N=CNC2=N1 MWBWWFOAEOYUST-UHFFFAOYSA-N 0.000 description 1
- WTLKTXIHIHFSGU-UHFFFAOYSA-N 2-nitrosoguanidine Chemical compound NC(N)=NN=O WTLKTXIHIHFSGU-UHFFFAOYSA-N 0.000 description 1
- KKAJSJJFBSOMGS-UHFFFAOYSA-N 3,6-diamino-10-methylacridinium chloride Chemical compound [Cl-].C1=C(N)C=C2[N+](C)=C(C=C(N)C=C3)C3=CC2=C1 KKAJSJJFBSOMGS-UHFFFAOYSA-N 0.000 description 1
- OSWFIVFLDKOXQC-UHFFFAOYSA-N 4-(3-methoxyphenyl)aniline Chemical compound COC1=CC=CC(C=2C=CC(N)=CC=2)=C1 OSWFIVFLDKOXQC-UHFFFAOYSA-N 0.000 description 1
- QFVHZQCOUORWEI-UHFFFAOYSA-N 4-[(4-anilino-5-sulfonaphthalen-1-yl)diazenyl]-5-hydroxynaphthalene-2,7-disulfonic acid Chemical compound C=12C(O)=CC(S(O)(=O)=O)=CC2=CC(S(O)(=O)=O)=CC=1N=NC(C1=CC=CC(=C11)S(O)(=O)=O)=CC=C1NC1=CC=CC=C1 QFVHZQCOUORWEI-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- LQLQRFGHAALLLE-UHFFFAOYSA-N 5-bromouracil Chemical compound BrC1=CNC(=O)NC1=O LQLQRFGHAALLLE-UHFFFAOYSA-N 0.000 description 1
- MHUWZNTUIIFHAS-XPWSMXQVSA-N 9-octadecenoic acid 1-[(phosphonoxy)methyl]-1,2-ethanediyl ester Chemical compound CCCCCCCC\C=C\CCCCCCCC(=O)OCC(COP(O)(O)=O)OC(=O)CCCCCCC\C=C\CCCCCCCC MHUWZNTUIIFHAS-XPWSMXQVSA-N 0.000 description 1
- 229930024421 Adenine Natural products 0.000 description 1
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 description 1
- 241000589155 Agrobacterium tumefaciens Species 0.000 description 1
- 108010083590 Apoproteins Proteins 0.000 description 1
- 102000006410 Apoproteins Human genes 0.000 description 1
- 108091023037 Aptamer Proteins 0.000 description 1
- 241000203069 Archaea Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 206010003591 Ataxia Diseases 0.000 description 1
- 206010003594 Ataxia telangiectasia Diseases 0.000 description 1
- 241000271566 Aves Species 0.000 description 1
- DWRXFEITVBNRMK-UHFFFAOYSA-N Beta-D-1-Arabinofuranosylthymine Natural products O=C1NC(=O)C(C)=CN1C1C(O)C(O)C(CO)O1 DWRXFEITVBNRMK-UHFFFAOYSA-N 0.000 description 1
- 102100026189 Beta-galactosidase Human genes 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- 101100421200 Caenorhabditis elegans sep-1 gene Proteins 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- 108090000565 Capsid Proteins Proteins 0.000 description 1
- 101710132601 Capsid protein Proteins 0.000 description 1
- 102000014914 Carrier Proteins Human genes 0.000 description 1
- 102100023321 Ceruloplasmin Human genes 0.000 description 1
- 108010077544 Chromatin Proteins 0.000 description 1
- 206010061765 Chromosomal mutation Diseases 0.000 description 1
- 101710094648 Coat protein Proteins 0.000 description 1
- 108010054814 DNA Gyrase Proteins 0.000 description 1
- 108010071146 DNA Polymerase III Proteins 0.000 description 1
- 102000007528 DNA Polymerase III Human genes 0.000 description 1
- 108090000323 DNA Topoisomerases Proteins 0.000 description 1
- 102000003915 DNA Topoisomerases Human genes 0.000 description 1
- 230000004544 DNA amplification Effects 0.000 description 1
- 238000012270 DNA recombination Methods 0.000 description 1
- 101100332287 Dictyostelium discoideum dst2 gene Proteins 0.000 description 1
- 102000016607 Diphtheria Toxin Human genes 0.000 description 1
- 108010053187 Diphtheria Toxin Proteins 0.000 description 1
- 241000255581 Drosophila <fruit fly, genus> Species 0.000 description 1
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
- 241000709661 Enterovirus Species 0.000 description 1
- 241000701959 Escherichia virus Lambda Species 0.000 description 1
- 241000702191 Escherichia virus P1 Species 0.000 description 1
- 241000701533 Escherichia virus T4 Species 0.000 description 1
- 108010007577 Exodeoxyribonuclease I Proteins 0.000 description 1
- 108091029865 Exogenous DNA Proteins 0.000 description 1
- 108010046276 FLP recombinase Proteins 0.000 description 1
- 241000192125 Firmicutes Species 0.000 description 1
- 241000233866 Fungi Species 0.000 description 1
- 108700028146 Genetic Enhancer Elements Proteins 0.000 description 1
- 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- 102000003886 Glycoproteins Human genes 0.000 description 1
- 108090000288 Glycoproteins Proteins 0.000 description 1
- 102100021181 Golgi phosphoprotein 3 Human genes 0.000 description 1
- 108091027305 Heteroduplex Proteins 0.000 description 1
- 108010014594 Heterogeneous Nuclear Ribonucleoprotein A1 Proteins 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- 101100005713 Homo sapiens CD4 gene Proteins 0.000 description 1
- 101100340738 Homo sapiens IL1B gene Proteins 0.000 description 1
- AVXURJPOCDRRFD-UHFFFAOYSA-N Hydroxylamine Chemical compound ON AVXURJPOCDRRFD-UHFFFAOYSA-N 0.000 description 1
- 108010021625 Immunoglobulin Fragments Proteins 0.000 description 1
- 102000008394 Immunoglobulin Fragments Human genes 0.000 description 1
- 102000017727 Immunoglobulin Variable Region Human genes 0.000 description 1
- 108010061833 Integrases Proteins 0.000 description 1
- 102000014150 Interferons Human genes 0.000 description 1
- 108010050904 Interferons Proteins 0.000 description 1
- 108010002352 Interleukin-1 Proteins 0.000 description 1
- 102000000589 Interleukin-1 Human genes 0.000 description 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- ODKSFYDXXFIFQN-BYPYZUCNSA-P L-argininium(2+) Chemical compound NC(=[NH2+])NCCC[C@H]([NH3+])C(O)=O ODKSFYDXXFIFQN-BYPYZUCNSA-P 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- ZDXPYRJPNDTMRX-VKHMYHEASA-N L-glutamine Chemical compound OC(=O)[C@@H](N)CCC(N)=O ZDXPYRJPNDTMRX-VKHMYHEASA-N 0.000 description 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 description 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 description 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 description 1
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 description 1
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 description 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 description 1
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 description 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 description 1
- 108091026898 Leader sequence (mRNA) Proteins 0.000 description 1
- 239000006137 Luria-Bertani broth Substances 0.000 description 1
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 description 1
- 239000004472 Lysine Substances 0.000 description 1
- 101710125418 Major capsid protein Proteins 0.000 description 1
- 241000124008 Mammalia Species 0.000 description 1
- 229910021380 Manganese Chloride Inorganic materials 0.000 description 1
- GLFNIEUTAYBVOC-UHFFFAOYSA-L Manganese chloride Chemical compound Cl[Mn]Cl GLFNIEUTAYBVOC-UHFFFAOYSA-L 0.000 description 1
- 101100383042 Mus musculus Cd4 gene Proteins 0.000 description 1
- 101100340743 Mus musculus Il1b gene Proteins 0.000 description 1
- ZRKWMRDKSOPRRS-UHFFFAOYSA-N N-Methyl-N-nitrosourea Chemical compound O=NN(C)C(N)=O ZRKWMRDKSOPRRS-UHFFFAOYSA-N 0.000 description 1
- PYUSHNKNPOHWEZ-YFKPBYRVSA-N N-formyl-L-methionine Chemical compound CSCC[C@@H](C(O)=O)NC=O PYUSHNKNPOHWEZ-YFKPBYRVSA-N 0.000 description 1
- VZUNGTLZRAYYDE-UHFFFAOYSA-N N-methyl-N'-nitro-N-nitrosoguanidine Chemical compound O=NN(C)C(=N)N[N+]([O-])=O VZUNGTLZRAYYDE-UHFFFAOYSA-N 0.000 description 1
- CHJJGSNFBQVOTG-UHFFFAOYSA-N N-methyl-guanidine Natural products CNC(N)=N CHJJGSNFBQVOTG-UHFFFAOYSA-N 0.000 description 1
- 108091007491 NSP3 Papain-like protease domains Proteins 0.000 description 1
- IOVCWXUNBOPUCH-UHFFFAOYSA-N Nitrous acid Chemical compound ON=O IOVCWXUNBOPUCH-UHFFFAOYSA-N 0.000 description 1
- 108091005461 Nucleic proteins Proteins 0.000 description 1
- 101710141454 Nucleoprotein Proteins 0.000 description 1
- 108700026244 Open Reading Frames Proteins 0.000 description 1
- 241000712464 Orthomyxoviridae Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000711504 Paramyxoviridae Species 0.000 description 1
- 208000002606 Paramyxoviridae Infections Diseases 0.000 description 1
- 206010034133 Pathogen resistance Diseases 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010067902 Peptide Library Proteins 0.000 description 1
- 229920001213 Polysorbate 20 Polymers 0.000 description 1
- 101710083689 Probable capsid protein Proteins 0.000 description 1
- WDVSHHCDHLJJJR-UHFFFAOYSA-N Proflavine Chemical compound C1=CC(N)=CC2=NC3=CC(N)=CC=C3C=C21 WDVSHHCDHLJJJR-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- 108010076504 Protein Sorting Signals Proteins 0.000 description 1
- 101900232935 Pyrococcus furiosus DNA polymerase Proteins 0.000 description 1
- 241001467519 Pyrococcus sp. Species 0.000 description 1
- 101000902578 Pyrococcus woesei DNA polymerase Proteins 0.000 description 1
- 101710086015 RNA ligase Proteins 0.000 description 1
- 108010092799 RNA-directed DNA polymerase Proteins 0.000 description 1
- 208000035415 Reinfection Diseases 0.000 description 1
- 108091081062 Repeated sequence (DNA) Proteins 0.000 description 1
- 241000283984 Rodentia Species 0.000 description 1
- 101710176276 SSB protein Proteins 0.000 description 1
- 241000242583 Scyphozoa Species 0.000 description 1
- MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 1
- 101710126859 Single-stranded DNA-binding protein Proteins 0.000 description 1
- DWAQJAXMDSEUJJ-UHFFFAOYSA-M Sodium bisulfite Chemical compound [Na+].OS([O-])=O DWAQJAXMDSEUJJ-UHFFFAOYSA-M 0.000 description 1
- NINIDFKCEFEMDL-UHFFFAOYSA-N Sulfur Chemical compound [S] NINIDFKCEFEMDL-UHFFFAOYSA-N 0.000 description 1
- 206010042566 Superinfection Diseases 0.000 description 1
- 210000001744 T-lymphocyte Anatomy 0.000 description 1
- 241001495444 Thermococcus sp. Species 0.000 description 1
- 241000204666 Thermotoga maritima Species 0.000 description 1
- 241000557720 Thermus brockianus Species 0.000 description 1
- 241000589499 Thermus thermophilus Species 0.000 description 1
- 108010085671 Thermus thermophilus DNA polymerase Proteins 0.000 description 1
- 108091036066 Three prime untranslated region Proteins 0.000 description 1
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 description 1
- 239000004473 Threonine Substances 0.000 description 1
- 108010001244 Tli polymerase Proteins 0.000 description 1
- 108700019146 Transgenes Proteins 0.000 description 1
- 239000007983 Tris buffer Substances 0.000 description 1
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 description 1
- 108010020713 Tth polymerase Proteins 0.000 description 1
- 108010046308 Type II DNA Topoisomerases Proteins 0.000 description 1
- 102000007537 Type II DNA Topoisomerases Human genes 0.000 description 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 description 1
- 108700005077 Viral Genes Proteins 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 238000010306 acid treatment Methods 0.000 description 1
- 229940023020 acriflavine Drugs 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 229960000643 adenine Drugs 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 125000001931 aliphatic group Chemical group 0.000 description 1
- 150000001408 amides Chemical class 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 230000000118 anti-neoplastic effect Effects 0.000 description 1
- 239000002518 antifoaming agent Substances 0.000 description 1
- 230000014102 antigen processing and presentation of exogenous peptide antigen via MHC class I Effects 0.000 description 1
- 239000002246 antineoplastic agent Substances 0.000 description 1
- 229940034982 antineoplastic agent Drugs 0.000 description 1
- 229940076005 apoptosis modulator Drugs 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- XKRFYHLGVUSROY-UHFFFAOYSA-N argon Substances [Ar] XKRFYHLGVUSROY-UHFFFAOYSA-N 0.000 description 1
- 229910052786 argon Inorganic materials 0.000 description 1
- 229910052785 arsenic Inorganic materials 0.000 description 1
- RQNWIZPPADIBDY-UHFFFAOYSA-N arsenic atom Chemical compound [As] RQNWIZPPADIBDY-UHFFFAOYSA-N 0.000 description 1
- MJLGNAGLHAQFHV-UHFFFAOYSA-N arsenopyrite Chemical compound [S-2].[Fe+3].[As-] MJLGNAGLHAQFHV-UHFFFAOYSA-N 0.000 description 1
- 229910052964 arsenopyrite Inorganic materials 0.000 description 1
- 125000003118 aryl group Chemical group 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 238000007845 assembly PCR Methods 0.000 description 1
- 230000037429 base substitution Effects 0.000 description 1
- 239000003782 beta lactam antibiotic agent Substances 0.000 description 1
- 108010005774 beta-Galactosidase Proteins 0.000 description 1
- IQFYYKKMVGJFEH-UHFFFAOYSA-N beta-L-thymidine Natural products O=C1NC(=O)C(C)=CN1C1OC(CO)C(O)C1 IQFYYKKMVGJFEH-UHFFFAOYSA-N 0.000 description 1
- 239000011230 binding agent Substances 0.000 description 1
- 108091008324 binding proteins Proteins 0.000 description 1
- 239000012620 biological material Substances 0.000 description 1
- 230000029918 bioluminescence Effects 0.000 description 1
- 238000005415 bioluminescence Methods 0.000 description 1
- 238000005422 blasting Methods 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 210000004899 c-terminal region Anatomy 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- OSQPUMRCKZAIOZ-UHFFFAOYSA-N carbon dioxide;ethanol Chemical compound CCO.O=C=O OSQPUMRCKZAIOZ-UHFFFAOYSA-N 0.000 description 1
- 239000003054 catalyst Substances 0.000 description 1
- 238000006555 catalytic reaction Methods 0.000 description 1
- 210000000170 cell membrane Anatomy 0.000 description 1
- 230000003833 cell viability Effects 0.000 description 1
- 230000005754 cellular signaling Effects 0.000 description 1
- 239000003153 chemical reaction reagent Substances 0.000 description 1
- 210000003483 chromatin Anatomy 0.000 description 1
- 239000003593 chromogenic compound Substances 0.000 description 1
- 239000003280 clastogen Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000008139 complexing agent Substances 0.000 description 1
- 238000004590 computer program Methods 0.000 description 1
- 238000005094 computer simulation Methods 0.000 description 1
- 230000001276 controlling effect Effects 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 description 1
- 235000018417 cysteine Nutrition 0.000 description 1
- 229940104302 cytosine Drugs 0.000 description 1
- 230000001419 dependent effect Effects 0.000 description 1
- 238000013461 design Methods 0.000 description 1
- 238000009792 diffusion process Methods 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 239000000539 dimer Substances 0.000 description 1
- SWSQBOPZIKWTGO-UHFFFAOYSA-N dimethylaminoamidine Natural products CN(C)C(N)=N SWSQBOPZIKWTGO-UHFFFAOYSA-N 0.000 description 1
- 238000009826 distribution Methods 0.000 description 1
- 230000009977 dual effect Effects 0.000 description 1
- 239000012149 elution buffer Substances 0.000 description 1
- 238000000295 emission spectrum Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000012869 ethanol precipitation Methods 0.000 description 1
- 238000000695 excitation spectrum Methods 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 108010052305 exodeoxyribonuclease III Proteins 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 235000013861 fat-free Nutrition 0.000 description 1
- 238000002189 fluorescence spectrum Methods 0.000 description 1
- 239000007850 fluorescent dye Substances 0.000 description 1
- 235000019253 formic acid Nutrition 0.000 description 1
- 238000005194 fractionation Methods 0.000 description 1
- 230000037433 frameshift Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 238000007429 general method Methods 0.000 description 1
- 102000034238 globular proteins Human genes 0.000 description 1
- 108091005896 globular proteins Proteins 0.000 description 1
- ZDXPYRJPNDTMRX-UHFFFAOYSA-N glutamine Natural products OC(=O)C(N)CCC(N)=O ZDXPYRJPNDTMRX-UHFFFAOYSA-N 0.000 description 1
- 150000004676 glycans Chemical class 0.000 description 1
- 239000004120 green S Substances 0.000 description 1
- 239000000122 growth hormone Substances 0.000 description 1
- 238000003306 harvesting Methods 0.000 description 1
- 238000013537 high throughput screening Methods 0.000 description 1
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
- 108091008039 hormone receptors Proteins 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 210000000987 immune system Anatomy 0.000 description 1
- 238000012750 in vivo screening Methods 0.000 description 1
- 238000011065 in-situ storage Methods 0.000 description 1
- 238000009399 inbreeding Methods 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 239000002919 insect venom Substances 0.000 description 1
- 238000007689 inspection Methods 0.000 description 1
- 239000000138 intercalating agent Substances 0.000 description 1
- 229940079322 interferon Drugs 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 230000005865 ionizing radiation Effects 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 230000001678 irradiating effect Effects 0.000 description 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 description 1
- 229930027917 kanamycin Natural products 0.000 description 1
- 229960000318 kanamycin Drugs 0.000 description 1
- SBUJHOSQTJFQJX-NOAMYHISSA-N kanamycin Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CN)O[C@@H]1O[C@H]1[C@H](O)[C@@H](O[C@@H]2[C@@H]([C@@H](N)[C@H](O)[C@@H](CO)O2)O)[C@H](N)C[C@@H]1N SBUJHOSQTJFQJX-NOAMYHISSA-N 0.000 description 1
- 229930182823 kanamycin A Natural products 0.000 description 1
- 230000002147 killing effect Effects 0.000 description 1
- 238000002372 labelling Methods 0.000 description 1
- 238000000670 ligand binding assay Methods 0.000 description 1
- 230000004807 localization Effects 0.000 description 1
- 230000033001 locomotion Effects 0.000 description 1
- 238000012423 maintenance Methods 0.000 description 1
- 230000014759 maintenance of location Effects 0.000 description 1
- 239000011565 manganese chloride Substances 0.000 description 1
- 235000002867 manganese chloride Nutrition 0.000 description 1
- 230000013011 mating Effects 0.000 description 1
- 230000007246 mechanism Effects 0.000 description 1
- 230000021121 meiosis Effects 0.000 description 1
- 239000012528 membrane Substances 0.000 description 1
- 108020004084 membrane receptors Proteins 0.000 description 1
- 102000006240 membrane receptors Human genes 0.000 description 1
- 229960000901 mepacrine Drugs 0.000 description 1
- 229960002523 mercuric chloride Drugs 0.000 description 1
- LWJROJCJINYWOX-UHFFFAOYSA-L mercury dichloride Chemical compound Cl[Hg]Cl LWJROJCJINYWOX-UHFFFAOYSA-L 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229910021645 metal ion Inorganic materials 0.000 description 1
- 229930182817 methionine Natural products 0.000 description 1
- 239000002480 mineral oil Substances 0.000 description 1
- 235000010446 mineral oil Nutrition 0.000 description 1
- 208000024191 minimally invasive lung adenocarcinoma Diseases 0.000 description 1
- 238000005065 mining Methods 0.000 description 1
- 230000033607 mismatch repair Effects 0.000 description 1
- 230000000869 mutational effect Effects 0.000 description 1
- UPSFMJHZUCSEHU-JYGUBCOQSA-N n-[(2s,3r,4r,5s,6r)-2-[(2r,3s,4r,5r,6s)-5-acetamido-4-hydroxy-2-(hydroxymethyl)-6-(4-methyl-2-oxochromen-7-yl)oxyoxan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide Chemical compound CC(=O)N[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@H]1[C@H](O)[C@@H](NC(C)=O)[C@H](OC=2C=C3OC(=O)C=C(C)C3=CC=2)O[C@@H]1CO UPSFMJHZUCSEHU-JYGUBCOQSA-N 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 102000044158 nucleic acid binding protein Human genes 0.000 description 1
- 108700020942 nucleic acid binding protein Proteins 0.000 description 1
- 150000003833 nucleoside derivatives Chemical class 0.000 description 1
- 125000003835 nucleoside group Chemical group 0.000 description 1
- 238000002515 oligonucleotide synthesis Methods 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 150000002482 oligosaccharides Chemical class 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000009400 out breeding Methods 0.000 description 1
- 230000003647 oxidation Effects 0.000 description 1
- 238000007254 oxidation reaction Methods 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- LCCNCVORNKJIRZ-UHFFFAOYSA-N parathion Chemical compound CCOP(=S)(OCC)OC1=CC=C([N+]([O-])=O)C=C1 LCCNCVORNKJIRZ-UHFFFAOYSA-N 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 230000001575 pathological effect Effects 0.000 description 1
- 108010011903 peptide receptors Proteins 0.000 description 1
- 102000014187 peptide receptors Human genes 0.000 description 1
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 description 1
- 150000004713 phosphodiesters Chemical class 0.000 description 1
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 1
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 238000011176 pooling Methods 0.000 description 1
- 229910001414 potassium ion Inorganic materials 0.000 description 1
- 229960000286 proflavine Drugs 0.000 description 1
- 230000009465 prokaryotic expression Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 230000004853 protein function Effects 0.000 description 1
- 230000006916 protein interaction Effects 0.000 description 1
- 150000003212 purines Chemical class 0.000 description 1
- GPKJTRJOBQGKQK-UHFFFAOYSA-N quinacrine Chemical compound C1=C(OC)C=C2C(NC(C)CCCN(CC)CC)=C(C=CC(Cl)=C3)C3=NC2=C1 GPKJTRJOBQGKQK-UHFFFAOYSA-N 0.000 description 1
- 238000011536 re-plating Methods 0.000 description 1
- 239000011541 reaction mixture Substances 0.000 description 1
- 238000005067 remediation Methods 0.000 description 1
- 108091035233 repetitive DNA sequence Proteins 0.000 description 1
- 102000053632 repetitive DNA sequence Human genes 0.000 description 1
- 230000032537 response to toxin Effects 0.000 description 1
- 230000002441 reversible effect Effects 0.000 description 1
- 238000012552 review Methods 0.000 description 1
- 102200076454 rs104894848 Human genes 0.000 description 1
- 102220065948 rs547125345 Human genes 0.000 description 1
- 102200031443 rs62508730 Human genes 0.000 description 1
- 102220180776 rs777479452 Human genes 0.000 description 1
- 238000007790 scraping Methods 0.000 description 1
- 238000010187 selection method Methods 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 238000010008 shearing Methods 0.000 description 1
- 230000035939 shock Effects 0.000 description 1
- 239000013605 shuttle vector Substances 0.000 description 1
- 229940047047 sodium arsenate Drugs 0.000 description 1
- MFBOGIVSZKQAPD-UHFFFAOYSA-M sodium butyrate Chemical compound [Na+].CCCC([O-])=O MFBOGIVSZKQAPD-UHFFFAOYSA-M 0.000 description 1
- 235000010267 sodium hydrogen sulphite Nutrition 0.000 description 1
- 229910001415 sodium ion Inorganic materials 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 238000000527 sonication Methods 0.000 description 1
- 238000012421 spiking Methods 0.000 description 1
- 230000002269 spontaneous effect Effects 0.000 description 1
- 238000010561 standard procedure Methods 0.000 description 1
- 230000035892 strand transfer Effects 0.000 description 1
- 229910052717 sulfur Inorganic materials 0.000 description 1
- 239000011593 sulfur Substances 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 230000004083 survival effect Effects 0.000 description 1
- 230000008685 targeting Effects 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 229940104230 thymidine Drugs 0.000 description 1
- RWQNBRDOKXIBIV-UHFFFAOYSA-N thymine Chemical group CC1=CNC(=O)NC1=O RWQNBRDOKXIBIV-UHFFFAOYSA-N 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
- 231100000419 toxicity Toxicity 0.000 description 1
- 230000001988 toxicity Effects 0.000 description 1
- 238000003151 transfection method Methods 0.000 description 1
- 230000010474 transient expression Effects 0.000 description 1
- 239000001226 triphosphate Substances 0.000 description 1
- 235000011178 triphosphate Nutrition 0.000 description 1
- UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
- LENZDBCJOHFCAS-UHFFFAOYSA-N tris Chemical compound OCC(N)(CO)CO LENZDBCJOHFCAS-UHFFFAOYSA-N 0.000 description 1
- 229910052721 tungsten Inorganic materials 0.000 description 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
- 238000002604 ultrasonography Methods 0.000 description 1
- 241000712461 unidentified influenza virus Species 0.000 description 1
- 238000002255 vaccination Methods 0.000 description 1
- 229960005486 vaccine Drugs 0.000 description 1
- 229910052720 vanadium Inorganic materials 0.000 description 1
- 108700026220 vif Genes Proteins 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 238000001262 western blot Methods 0.000 description 1
- 229910052727 yttrium Inorganic materials 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 239000002132 β-lactam antibiotic Substances 0.000 description 1
- 229940124586 β-lactam antibiotics Drugs 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C40—COMBINATORIAL TECHNOLOGY
- C40B—COMBINATORIAL CHEMISTRY; LIBRARIES, e.g. CHEMICAL LIBRARIES
- C40B40/00—Libraries per se, e.g. arrays, mixtures
- C40B40/02—Libraries contained in or displayed by microorganisms, e.g. bacteria or animal cells; Libraries contained in or displayed by vectors, e.g. plasmids; Libraries containing only microorganisms or vectors
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/43504—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates
- C07K14/43595—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from invertebrates from coelenteratae, e.g. medusae
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/545—IL-1
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/102—Mutagenizing nucleic acids
- C12N15/1027—Mutagenizing nucleic acids by DNA shuffling, e.g. RSR, STEP, RPR
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1037—Screening libraries presented on the surface of microorganisms, e.g. phage display, E. coli display
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
- C12N15/1034—Isolating an individual clone by screening libraries
- C12N15/1058—Directional evolution of libraries, e.g. evolution of libraries is achieved by mutagenesis and screening or selection of mixed population of organisms
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/52—Genes encoding for enzymes or proenzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/64—General methods for preparing the vector, for introducing it into the cell or for selecting the vector-containing host
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/24—Hydrolases (3) acting on glycosyl compounds (3.2)
- C12N9/2402—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
- C12N9/2468—Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1) acting on beta-galactose-glycoside bonds, e.g. carrageenases (3.2.1.83; 3.2.1.157); beta-agarase (3.2.1.81)
- C12N9/2471—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/14—Hydrolases (3)
- C12N9/78—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5)
- C12N9/86—Hydrolases (3) acting on carbon to nitrogen bonds other than peptide bonds (3.5) acting on amide bonds in cyclic amides, e.g. penicillinase (3.5.2)
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6811—Selection methods for production or design of target specific oligonucleotides or binding molecules
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y302/00—Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
- C12Y302/01—Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
- C12Y302/01023—Beta-galactosidase (3.2.1.23), i.e. exo-(1-->4)-beta-D-galactanase
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y305/00—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5)
- C12Y305/02—Hydrolases acting on carbon-nitrogen bonds, other than peptide bonds (3.5) in cyclic amides (3.5.2)
- C12Y305/02006—Beta-lactamase (3.5.2.6)
-
- H—ELECTRICITY
- H10—SEMICONDUCTOR DEVICES; ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10N—ELECTRIC SOLID-STATE DEVICES NOT OTHERWISE PROVIDED FOR
- H10N60/00—Superconducting devices
- H10N60/10—Junction-based devices
- H10N60/128—Junction-based devices having three or more electrodes, e.g. transistor-like structures
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/50—Immunoglobulins specific features characterized by immunoglobulin fragments
- C07K2317/56—Immunoglobulins specific features characterized by immunoglobulin fragments variable (Fv) region, i.e. VH and/or VL
- C07K2317/565—Complementarity determining region [CDR]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2317/00—Immunoglobulins specific features
- C07K2317/60—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments
- C07K2317/62—Immunoglobulins specific features characterized by non-natural combinations of immunoglobulin fragments comprising only variable region components
- C07K2317/622—Single chain antibody (scFv)
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Biophysics (AREA)
- Physics & Mathematics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicinal Chemistry (AREA)
- Plant Pathology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Immunology (AREA)
- Toxicology (AREA)
- Analytical Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Bioinformatics & Computational Biology (AREA)
- Ecology (AREA)
- Cell Biology (AREA)
- General Chemical & Material Sciences (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/564,955 US5811238A (en) | 1994-02-17 | 1995-11-30 | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US08/621,859 US6117679A (en) | 1994-02-17 | 1996-03-25 | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE69615411D1 DE69615411D1 (de) | 2001-10-25 |
| DE69615411T2 true DE69615411T2 (de) | 2002-06-20 |
Family
ID=27073702
Family Applications (4)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE69615411T Expired - Fee Related DE69615411T2 (de) | 1995-11-30 | 1996-12-02 | Verfahren zur Herstellung von Polynucleotiden mit erwünschten Eigenschaften mittels wiederholter Selektion und Rekombination |
| DE0876509T Pending DE876509T1 (de) | 1995-11-30 | 1996-12-02 | Verfahren zur herstellung von polynukleotiden mit gewünschten eigenschaftendurch iterative selektion und rekombination |
| DE0911396T Pending DE911396T1 (de) | 1995-11-30 | 1996-12-02 | Verfahren zur Herstellung von Polynucleotiden mit erwünschten Eigenschaften mittels wiederholter Selektion und Rekombination |
| DE69615406T Expired - Lifetime DE69615406T3 (de) | 1995-11-30 | 1996-12-02 | Verfahren zur herstellung von polynukleotiden mit gewünschten eigenschaften durch iterative selektion und rekombination |
Family Applications After (3)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE0876509T Pending DE876509T1 (de) | 1995-11-30 | 1996-12-02 | Verfahren zur herstellung von polynukleotiden mit gewünschten eigenschaftendurch iterative selektion und rekombination |
| DE0911396T Pending DE911396T1 (de) | 1995-11-30 | 1996-12-02 | Verfahren zur Herstellung von Polynucleotiden mit erwünschten Eigenschaften mittels wiederholter Selektion und Rekombination |
| DE69615406T Expired - Lifetime DE69615406T3 (de) | 1995-11-30 | 1996-12-02 | Verfahren zur herstellung von polynukleotiden mit gewünschten eigenschaften durch iterative selektion und rekombination |
Country Status (11)
| Country | Link |
|---|---|
| US (8) | US6117679A (enExample) |
| EP (4) | EP0876509B2 (enExample) |
| JP (3) | JP4015193B2 (enExample) |
| AT (2) | ATE205878T1 (enExample) |
| AU (1) | AU713952B2 (enExample) |
| CA (1) | CA2239099C (enExample) |
| DE (4) | DE69615411T2 (enExample) |
| DK (2) | DK0876509T4 (enExample) |
| ES (2) | ES2165124T3 (enExample) |
| IL (1) | IL124675A0 (enExample) |
| WO (1) | WO1997020078A1 (enExample) |
Families Citing this family (650)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6309883B1 (en) | 1994-02-17 | 2001-10-30 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US20060257890A1 (en) | 1996-05-20 | 2006-11-16 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5837458A (en) | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6335160B1 (en) * | 1995-02-17 | 2002-01-01 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6995017B1 (en) | 1994-02-17 | 2006-02-07 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6165793A (en) * | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6395547B1 (en) | 1994-02-17 | 2002-05-28 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6117679A (en) | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6406855B1 (en) | 1994-02-17 | 2002-06-18 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US6808904B2 (en) | 1994-06-16 | 2004-10-26 | Syngenta Participations Ag | Herbicide-tolerant protox genes produced by DNA shuffling |
| US6936289B2 (en) | 1995-06-07 | 2005-08-30 | Danisco A/S | Method of improving the properties of a flour dough, a flour dough improving composition and improved food products |
| US5958672A (en) | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
| US6361974B1 (en) | 1995-12-07 | 2002-03-26 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
| US5830696A (en) | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
| US6562594B1 (en) | 1999-09-29 | 2003-05-13 | Diversa Corporation | Saturation mutagenesis in directed evolution |
| US6352842B1 (en) | 1995-12-07 | 2002-03-05 | Diversa Corporation | Exonucease-mediated gene assembly in directed evolution |
| US6939689B2 (en) | 1995-12-07 | 2005-09-06 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
| US20020028443A1 (en) * | 1999-09-27 | 2002-03-07 | Jay M. Short | Method of dna shuffling with polynucleotides produced by blocking or interrupting a synthesis or amplification process |
| US20030215798A1 (en) | 1997-06-16 | 2003-11-20 | Diversa Corporation | High throughput fluorescence-based screening for novel enzymes |
| US7018793B1 (en) | 1995-12-07 | 2006-03-28 | Diversa Corporation | Combinatorial screening of mixed populations of organisms |
| US6740506B2 (en) | 1995-12-07 | 2004-05-25 | Diversa Corporation | End selection in directed evolution |
| US5965408A (en) | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
| US6764835B2 (en) | 1995-12-07 | 2004-07-20 | Diversa Corporation | Saturation mutageneis in directed evolution |
| US6537776B1 (en) | 1999-06-14 | 2003-03-25 | Diversa Corporation | Synthetic ligation reassembly in directed evolution |
| US6713279B1 (en) | 1995-12-07 | 2004-03-30 | Diversa Corporation | Non-stochastic generation of genetic vaccines and enzymes |
| US6358709B1 (en) | 1995-12-07 | 2002-03-19 | Diversa Corporation | End selection in directed evolution |
| US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
| US6096548A (en) * | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| US6506602B1 (en) | 1996-03-25 | 2003-01-14 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6696251B1 (en) | 1996-05-31 | 2004-02-24 | Board Of Trustees Of The University Of Illinois | Yeast cell surface display of proteins and uses thereof |
| US6773910B1 (en) | 1996-07-10 | 2004-08-10 | Walter Brieden | Method of preparing (S)- or (R) -3,3,3-trifluoro-2-hydroxy-2-methylpropionic acid |
| US6025485A (en) | 1997-02-14 | 2000-02-15 | Arcaris, Inc. | Methods and compositions for peptide libraries displayed on light-emitting scaffolds |
| US5955275A (en) * | 1997-02-14 | 1999-09-21 | Arcaris, Inc. | Methods for identifying nucleic acid sequences encoding agents that affect cellular phenotypes |
| US20070009930A1 (en) * | 1996-12-18 | 2007-01-11 | Maxygen, Inc. | Methods and compositions for polypeptide engineering |
| US7148054B2 (en) * | 1997-01-17 | 2006-12-12 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| WO1998031837A1 (en) | 1997-01-17 | 1998-07-23 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| US6326204B1 (en) | 1997-01-17 | 2001-12-04 | Maxygen, Inc. | Evolution of whole cells and organisms by recursive sequence recombination |
| GB9701425D0 (en) | 1997-01-24 | 1997-03-12 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
| US6623922B1 (en) | 1997-02-14 | 2003-09-23 | Deltagen Proteomics | Methods for identifying, characterizing, and evolving cell-type specific CIS regulatory elements |
| US6159687A (en) | 1997-03-18 | 2000-12-12 | Novo Nordisk A/S | Methods for generating recombined polynucleotides |
| US6159688A (en) | 1997-03-18 | 2000-12-12 | Novo Nordisk A/S | Methods of producing polynucleotide variants |
| US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
| ATE280221T1 (de) | 1997-04-09 | 2004-11-15 | Danisco | Verwendung von lipase zur verbesserung von teigen und backwaren |
| US6046925A (en) * | 1997-04-14 | 2000-04-04 | The Regents Of The University Of California | Photochromic fluorescent proteins and optical memory storage devices based on fluorescent proteins |
| GB9712512D0 (en) | 1997-06-16 | 1997-08-20 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
| DE19725371B4 (de) * | 1997-06-16 | 2005-01-20 | Bornholdt, Stefan, Dr. | Verfahren zur Beschleunigung der evolutiven Optimierung von Biopolymeren und zur Verbesserung der damit hergestellten Biopolymere |
| DE19737562A1 (de) * | 1997-08-28 | 1999-05-06 | Otogene Biotechnologische Fors | Verfahren zur Identifizierung von Wechselwirkungen zwischen Proteinen bzw. Peptiden |
| GB9722131D0 (en) * | 1997-10-20 | 1997-12-17 | Medical Res Council | Method |
| AU1124499A (en) | 1997-10-28 | 1999-05-17 | Maxygen, Inc. | Human papillomavirus vectors |
| US6596539B1 (en) * | 1997-10-31 | 2003-07-22 | Maxygen, Inc. | Modification of virus tropism and host range by viral genome shuffling |
| US6156509A (en) * | 1997-11-12 | 2000-12-05 | Genencor International, Inc. | Method of increasing efficiency of directed evolution of a gene using phagemid |
| EP2270234B1 (en) | 1997-12-08 | 2013-03-06 | California Institute of Technology | Method for creating polynucleotide and polypeptide sequences |
| AR017831A1 (es) | 1997-12-10 | 2001-10-24 | Pioneer Hi Bred Int | Metodo para alterar la composicion de aminoacidos de una proteina nativa de interes, proteina elaborada, y polinucleotido |
| EP1555316A3 (en) * | 1998-02-11 | 2008-01-30 | Maxygen, Inc. | Antigen library immunization |
| JP2002507393A (ja) * | 1998-02-11 | 2002-03-12 | マキシジェン, インコーポレイテッド | 抗原ライブラリー免疫 |
| EP1518927A3 (en) * | 1998-02-11 | 2005-06-22 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
| US6541011B2 (en) | 1998-02-11 | 2003-04-01 | Maxygen, Inc. | Antigen library immunization |
| JP2002503461A (ja) * | 1998-02-11 | 2002-02-05 | マキシジェン, インコーポレイテッド | 遺伝子ワクチンベクター工学 |
| DE19805334A1 (de) * | 1998-02-11 | 1999-08-12 | Otogene Biotechnologische Fors | Verfahren zur Entwicklung eines pharmazeutischen Wirkstoffes |
| US7390619B1 (en) | 1998-02-11 | 2008-06-24 | Maxygen, Inc. | Optimization of immunomodulatory properties of genetic vaccines |
| AU2535599A (en) * | 1998-02-17 | 1999-08-30 | Zeneca Limited | Insecticidal peptides |
| KR20010082543A (ko) | 1998-05-01 | 2001-08-30 | 추후제출 | Dna 재편성을 이용한 내병충성 유전자의 최적화 방법 |
| US6902918B1 (en) | 1998-05-21 | 2005-06-07 | California Institute Of Technology | Oxygenase enzymes and screening method |
| US7153655B2 (en) * | 1998-06-16 | 2006-12-26 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function involving the use of exonuclease enzyme and two populations of parent polynucleotide sequence |
| KR20010052894A (ko) | 1998-06-17 | 2001-06-25 | 맥시겐, 인크. | 목적하는 특성을 보유한 폴리뉴클레오티드를 생성하는 방법 |
| US6365408B1 (en) | 1998-06-19 | 2002-04-02 | Maxygen, Inc. | Methods of evolving a polynucleotides by mutagenesis and recombination |
| IL140100A0 (en) * | 1998-06-29 | 2002-02-10 | Phylos Inc | Methods of generating highly diverse libraries |
| DE69904941T3 (de) | 1998-07-21 | 2008-01-31 | Danisco A/S | Lebensmittel |
| JP2003503005A (ja) * | 1998-07-28 | 2003-01-28 | カリフォルニア インスティチュート オブ テクノロジー | 機能的真核生物タンパク質の発現 |
| US20040191772A1 (en) * | 1998-08-12 | 2004-09-30 | Dupret Daniel Marc | Method of shuffling polynucleotides using templates |
| US6991922B2 (en) * | 1998-08-12 | 2006-01-31 | Proteus S.A. | Process for in vitro creation of recombinant polynucleotide sequences by oriented ligation |
| US20030104417A1 (en) * | 1998-08-12 | 2003-06-05 | Proteus S.A. | Template-mediated, ligation-oriented method of nonrandomly shuffling polynucleotides |
| US20020058249A1 (en) * | 1998-08-12 | 2002-05-16 | Venkiteswaran Subramanian | Dna shuffling to produce herbicide selective crops |
| US20030092023A1 (en) * | 1998-08-12 | 2003-05-15 | Daniel Dupret | Method of shuffling polynucleotides using templates |
| EP1104459A1 (en) | 1998-08-12 | 2001-06-06 | Maxygen, Inc. | Dna shuffling of monooxygenase genes for production of industrial chemicals |
| US6951719B1 (en) * | 1999-08-11 | 2005-10-04 | Proteus S.A. | Process for obtaining recombined nucleotide sequences in vitro, libraries of sequences and sequences thus obtained |
| JP4704565B2 (ja) | 1998-09-23 | 2011-06-15 | ザイモジェネティクス, インコーポレイテッド | サイトカインレセプターzalpha11 |
| EP1119616A2 (en) * | 1998-10-07 | 2001-08-01 | Maxygen, Inc. | Dna shuffling to produce nucleic acids for mycotoxin detoxification |
| EP1129182A1 (en) * | 1998-11-10 | 2001-09-05 | Maxygen, Inc. | Modified ribulose 1,5-bisphosphate carboxylase/oxygenase |
| EP1129184A1 (en) | 1998-11-10 | 2001-09-05 | Maxygen, Inc. | Modified adp-glucose pyrophosphorylase for improvement and optimation of plant phenotypes |
| US6438561B1 (en) * | 1998-11-19 | 2002-08-20 | Navigation Technologies Corp. | Method and system for using real-time traffic broadcasts with navigation systems |
| IT1303776B1 (it) * | 1998-11-19 | 2001-02-23 | S I S S A Scuola Internaz Supe | Processo per la preparazione di genoteche, di polipeptidi utilizzandodette genoteche e i polipepti ottenuti. |
| US20040005673A1 (en) * | 2001-06-29 | 2004-01-08 | Kevin Jarrell | System for manipulating nucleic acids |
| US6358712B1 (en) | 1999-01-05 | 2002-03-19 | Trustee Of Boston University | Ordered gene assembly |
| DE60042730D1 (de) | 1999-01-05 | 2009-09-24 | Univ Boston | Verbessertes klonierungsverfahren |
| DK1642972T3 (da) | 1999-01-07 | 2010-05-10 | Zymogenetics Inc | Terapeutisk anvendelse af BR43X2 opløselige receptorer |
| CA2337949C (en) * | 1999-01-18 | 2011-03-15 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| US6376246B1 (en) | 1999-02-05 | 2002-04-23 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6368861B1 (en) | 1999-01-19 | 2002-04-09 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US20030054390A1 (en) * | 1999-01-19 | 2003-03-20 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US6917882B2 (en) * | 1999-01-19 | 2005-07-12 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| US6436675B1 (en) | 1999-09-28 | 2002-08-20 | Maxygen, Inc. | Use of codon-varied oligonucleotide synthesis for synthetic shuffling |
| EP1151409A1 (en) * | 1999-01-18 | 2001-11-07 | Maxygen, Inc. | Methods of populating data stuctures for use in evolutionary simulations |
| US7873477B1 (en) | 2001-08-21 | 2011-01-18 | Codexis Mayflower Holdings, Llc | Method and system using systematically varied data libraries |
| KR20010042037A (ko) * | 1999-01-19 | 2001-05-25 | 맥시겐, 인크. | 목적으로 하는 특징을 갖는 문자열인, 폴리뉴클레오타이드및 폴리펩타이드의 제작 방법 |
| US20070065838A1 (en) * | 1999-01-19 | 2007-03-22 | Maxygen, Inc. | Oligonucleotide mediated nucleic acid recombination |
| US7702464B1 (en) | 2001-08-21 | 2010-04-20 | Maxygen, Inc. | Method and apparatus for codon determining |
| EP1108783A3 (en) * | 1999-01-19 | 2001-09-05 | Maxygen, Inc. | Oligonucleotide-mediated nucleic acid recombination |
| US7024312B1 (en) * | 1999-01-19 | 2006-04-04 | Maxygen, Inc. | Methods for making character strings, polynucleotides and polypeptides having desired characteristics |
| US6961664B2 (en) | 1999-01-19 | 2005-11-01 | Maxygen | Methods of populating data structures for use in evolutionary simulations |
| US8457903B1 (en) | 1999-01-19 | 2013-06-04 | Codexis Mayflower Holdings, Llc | Method and/or apparatus for determining codons |
| MXPA00009723A (es) * | 1999-02-04 | 2003-09-22 | Diversa Corp | Generacion no estocastica de vacunas y enzimas geneticas. |
| US20090130718A1 (en) * | 1999-02-04 | 2009-05-21 | Diversa Corporation | Gene site saturation mutagenesis |
| US7384387B1 (en) | 1999-02-11 | 2008-06-10 | Maxygen, Inc. | High throughput mass spectrometry |
| JP3399518B2 (ja) * | 1999-03-03 | 2003-04-21 | インターナショナル・ビジネス・マシーンズ・コーポレーション | 半導体構造およびその製造方法 |
| CA2362737A1 (en) | 1999-03-05 | 2000-09-08 | Maxygen, Inc. | Recombination of insertion modified nucleic acids |
| US6531316B1 (en) | 1999-03-05 | 2003-03-11 | Maxyag, Inc. | Encryption of traits using split gene sequences and engineered genetic elements |
| AU3879300A (en) * | 1999-03-09 | 2000-09-28 | Diversa Corporation | End selection in directed evolution |
| EP2295577A3 (en) | 1999-03-09 | 2012-08-08 | ZymoGenetics, Inc. | Human cytokine as ligand of the z-alpha receptor and uses thereof |
| US8148110B2 (en) * | 1999-03-15 | 2012-04-03 | The Board Of Trustees Of The Leland Stanford Junior University | Detection of molecular interactions by β-lactamase reporter fragment complementation |
| AU2005225057A1 (en) * | 1999-03-26 | 2005-12-01 | Bp Corporation North America Inc. | Synthetic ligation reassembly in directed evolution |
| CA2329122A1 (en) * | 1999-03-26 | 2000-10-05 | Diversa Corporation | Exonuclease-mediated nucleic acid reassembly in directed evolution |
| US20040137515A1 (en) * | 1999-06-21 | 2004-07-15 | Gary Lynch | Methods and device for in vitro detection and characterization of psychoactives using analysis of repetitive electrical activity in a neuronal sample |
| JP2003503039A (ja) * | 1999-06-25 | 2003-01-28 | マキシジェン, インコーポレイテッド | 弱毒化したワクチンの操作のための方法および組成物 |
| WO2001004287A1 (en) * | 1999-07-07 | 2001-01-18 | Maxygen Aps | A method for preparing modified polypeptides |
| ES2286029T3 (es) | 1999-07-07 | 2007-12-01 | Zymogenetics Inc | Receptor de citocina humano. |
| US7179638B2 (en) | 1999-07-30 | 2007-02-20 | Large Scale Biology Corporation | Microarrays and their manufacture by slicing |
| US6713309B1 (en) | 1999-07-30 | 2004-03-30 | Large Scale Proteomics Corporation | Microarrays and their manufacture |
| NZ516517A (en) | 1999-08-12 | 2003-10-31 | Pfizer Prod Inc | Mutations in the aveC allele of Streptomyces avermitilis gene that reduce the ratio of cyclohexyl B2:cyclohexyl B1 avermectins |
| US6586230B1 (en) * | 2000-10-27 | 2003-07-01 | Lexicon Genetics Incorporated | Human kinase and polynucleotides encoding the same |
| US6797510B1 (en) * | 2001-05-24 | 2004-09-28 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
| US20080050809A1 (en) * | 1999-09-28 | 2008-02-28 | Alejandro Abuin | Novel human kinases and polynucleotides encoding the same |
| US20040002474A1 (en) * | 1999-10-07 | 2004-01-01 | Maxygen Inc. | IFN-alpha homologues |
| US7430477B2 (en) * | 1999-10-12 | 2008-09-30 | Maxygen, Inc. | Methods of populating data structures for use in evolutionary simulations |
| WO2001032829A2 (en) * | 1999-11-05 | 2001-05-10 | Novozymes A/S | Methods to screen microorganisms or gene libraries for products secreted from a cell |
| DE19953854C2 (de) | 1999-11-09 | 2002-01-17 | Max Planck Gesellschaft | Verfahren zur Herstellung von Biopolymeren mit veränderten Eigenschaften |
| US6686515B1 (en) | 1999-11-23 | 2004-02-03 | Maxygen, Inc. | Homologous recombination in plants |
| US7115712B1 (en) | 1999-12-02 | 2006-10-03 | Maxygen, Inc. | Cytokine polypeptides |
| EP2194130A1 (en) | 1999-12-23 | 2010-06-09 | ZymoGenetics, L.L.C. | Cytokine ZCYTO18 |
| ES2327606T3 (es) | 2000-01-10 | 2009-11-02 | Maxygen Holdings Ltd | Conjugados de g-csf. |
| IL150291A0 (en) * | 2000-01-11 | 2002-12-01 | Maxygen Inc | Integrated systems and methods for diversity generation and screening |
| MXPA02007078A (es) | 2000-02-09 | 2003-03-27 | Basf Ag | Nuevo gen de elongasa y procedimiento para la obtencion de acidos grasos poliinsaturados. |
| WO2001058935A2 (en) | 2000-02-11 | 2001-08-16 | Maxygen Aps | FACTOR VII OR VIIa-LIKE MOLECULES |
| WO2001064864A2 (en) * | 2000-02-28 | 2001-09-07 | Maxygen, Inc. | Single-stranded nucleic acid template-mediated recombination and nucleic acid fragment isolation |
| AU2001247676A1 (en) * | 2000-03-21 | 2001-10-03 | Neugenesis Corporation | Methods for in vivo diversification of single genes |
| US20010049104A1 (en) * | 2000-03-24 | 2001-12-06 | Stemmer Willem P.C. | Methods for modulating cellular and organismal phenotypes |
| WO2001075767A2 (en) * | 2000-03-30 | 2001-10-11 | Maxygen, Inc. | In silico cross-over site selection |
| EP1303602B1 (en) | 2000-04-05 | 2006-12-27 | ZymoGenetics, Inc. | Soluble zalpha11 cytokine receptors |
| US7115403B1 (en) | 2000-05-16 | 2006-10-03 | The California Institute Of Technology | Directed evolution of galactose oxidase enzymes |
| US6479262B1 (en) | 2000-05-16 | 2002-11-12 | Hercules, Incorporated | Solid phase enzymatic assembly of polynucleotides |
| US20020045175A1 (en) * | 2000-05-23 | 2002-04-18 | Zhen-Gang Wang | Gene recombination and hybrid protein development |
| US20030032059A1 (en) * | 2000-05-23 | 2003-02-13 | Zhen-Gang Wang | Gene recombination and hybrid protein development |
| US6686188B2 (en) | 2000-05-26 | 2004-02-03 | Amersham Plc | Polynucleotide encoding a human myosin-like polypeptide expressed predominantly in heart and muscle |
| EP1360290A2 (en) * | 2000-06-23 | 2003-11-12 | Maxygen, Inc. | Co-stimulatory molecules |
| AU2001268716A1 (en) | 2000-06-23 | 2002-01-08 | Maxygen, Inc. | Novel chimeric promoters |
| AU2001273032A1 (en) | 2000-06-26 | 2002-01-08 | Zymogenetics Inc. | Cytokine receptor zcytor17 |
| EP2281878A1 (en) | 2000-06-26 | 2011-02-09 | Novozymes A/S | Lipolytic enzyme |
| US7846733B2 (en) * | 2000-06-26 | 2010-12-07 | Nugen Technologies, Inc. | Methods and compositions for transcription-based nucleic acid amplification |
| AU2001271912A1 (en) * | 2000-07-07 | 2002-01-21 | Maxygen, Inc. | Molecular breeding of transposable elements |
| US6994963B1 (en) * | 2000-07-10 | 2006-02-07 | Ambion, Inc. | Methods for recombinatorial nucleic acid synthesis |
| US6858422B2 (en) * | 2000-07-13 | 2005-02-22 | Codexis, Inc. | Lipase genes |
| US7087415B2 (en) * | 2000-07-31 | 2006-08-08 | Athena Biotechnologies, Inc. | Methods and compositions for directed gene assembly |
| US20020132308A1 (en) * | 2000-08-24 | 2002-09-19 | Mpep @ Page 300-M | Novel constructs and their use in metabolic pathway engineering |
| AU2001288478B2 (en) | 2000-08-25 | 2006-11-02 | Basf Plant Science Gmbh | Plant polynucleotides encoding prenyl proteases |
| WO2002022810A2 (en) * | 2000-09-15 | 2002-03-21 | Diversa Corporation | Combinatorial screening of mixed populations of organisms |
| AU2002213183A1 (en) | 2000-10-12 | 2002-04-22 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
| US6912470B2 (en) * | 2001-05-21 | 2005-06-28 | Ecopia Biosciences, Inc. | Genes and proteins involved in the biosynthesis of enediyne ring structures |
| US7045283B2 (en) | 2000-10-18 | 2006-05-16 | The Regents Of The University Of California | Methods of high-throughput screening for internalizing antibodies |
| US7202070B2 (en) * | 2000-10-31 | 2007-04-10 | Biocatalytics, Inc. | Method for reductive amination of a ketone using a mutated enzyme |
| WO2002042438A2 (en) | 2000-11-20 | 2002-05-30 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
| US6958213B2 (en) * | 2000-12-12 | 2005-10-25 | Alligator Bioscience Ab | Method for in vitro molecular evolution of protein function |
| WO2002048333A2 (en) * | 2000-12-12 | 2002-06-20 | Lexicon Genetics Incorporated | Novel human kinases and uses thereof |
| PT1341909E (pt) * | 2000-12-12 | 2005-10-31 | Alligator Bioscience Ab | Metodo para a evolucao molecular in vitro da funcao de proteina |
| GB2370038B (en) * | 2000-12-12 | 2003-03-26 | Bioinvent Int Ab | A method for in vitro molecular evolution of protein function |
| AU2002228974A1 (en) * | 2000-12-13 | 2002-06-24 | Nugen Technologies, Inc | Methods and compositions for generation of multiple copies of nucleic acid sequences and methods of detection thereof |
| US20020086292A1 (en) | 2000-12-22 | 2002-07-04 | Shigeaki Harayama | Synthesis of hybrid polynucleotide molecules using single-stranded polynucleotide molecules |
| US20020150895A1 (en) * | 2000-12-22 | 2002-10-17 | Raymond Wheeler | Method and apparatus for filtering and extending RNA alignment coverage |
| WO2002059325A2 (en) * | 2000-12-27 | 2002-08-01 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
| US6849443B2 (en) * | 2001-01-23 | 2005-02-01 | Lexicon Genetics Incorporated | Human kinases and polynucleotides encoding the same |
| US8008459B2 (en) * | 2001-01-25 | 2011-08-30 | Evolva Sa | Concatemers of differentially expressed multiple genes |
| EP1356037B1 (en) * | 2001-01-25 | 2011-03-09 | Evolva Ltd. | A library of a collection of cells |
| JP2004517638A (ja) * | 2001-02-02 | 2004-06-17 | マックス−プランク−ゲゼルシャフト・ツア・フェルデルング・デア・ヴィッセンシャフテン・エー・ファオ | 機能的核酸の同定方法 |
| US20050003354A1 (en) * | 2001-02-21 | 2005-01-06 | Maxygen, Inc. | Methods for improving or altering promoter/enhancer properties |
| WO2002072772A2 (en) * | 2001-03-09 | 2002-09-19 | Nugen Technologies, Inc. | Methods and compositions for amplification of rna sequences |
| WO2002074932A2 (en) | 2001-03-20 | 2002-09-26 | Lexicon Genetics Incorporated | Novel human kinase and polynucleotides encoding the same |
| US20030087254A1 (en) * | 2001-04-05 | 2003-05-08 | Simon Delagrave | Methods for the preparation of polynucleotide libraries and identification of library members having desired characteristics |
| CA2443516A1 (en) * | 2001-04-06 | 2002-10-17 | Lexicon Genetics Incorporated | Novel human kinases and polynucleotides encoding the same |
| WO2002083868A2 (en) | 2001-04-16 | 2002-10-24 | California Institute Of Technology | Peroxide-driven cytochrome p450 oxygenase variants |
| AU2002258997A1 (en) * | 2001-04-24 | 2002-11-05 | Li-Cor, Inc. | Polymerases with charge-switch activity and methods of generating such polymerases |
| JP2004528850A (ja) * | 2001-05-03 | 2004-09-24 | レンセレアー ポリテクニック インスティテュート | 定方向進化の新規方法 |
| EP1463749A4 (en) | 2001-05-09 | 2005-04-13 | Lexicon Genetics Inc | NEW HUMAN KINASES AND THESE CODING POLYNUCLEOTIDES |
| CA2444960C (en) | 2001-05-18 | 2011-08-09 | Danisco A/S | Method of improving dough and bread quality |
| CA2447240C (en) * | 2001-05-18 | 2013-02-19 | Wisconsin Alumni Research Foundation | Method for the synthesis of dna sequences |
| EP2298868B1 (en) | 2001-06-26 | 2015-01-07 | Novozymes A/S | Polypeptides having cellobiohydrolase I activity and polynucleotides encoding same |
| US20030143612A1 (en) * | 2001-07-18 | 2003-07-31 | Pointilliste, Inc. | Collections of binding proteins and tags and uses thereof for nested sorting and high throughput screening |
| WO2003008563A2 (en) | 2001-07-20 | 2003-01-30 | California Institute Of Technology | Improved cytochrome p450 oxygenases |
| DE60210096D1 (de) * | 2001-07-26 | 2006-05-11 | Ecopia Biosciences Inc | Gene und proteine zur rosaramicin biosynthese |
| US8067556B2 (en) * | 2001-07-26 | 2011-11-29 | Agilent Technologies, Inc. | Multi-site mutagenesis |
| US6833441B2 (en) | 2001-08-01 | 2004-12-21 | Abmaxis, Inc. | Compositions and methods for generating chimeric heteromultimers |
| US20040078837A1 (en) * | 2001-08-02 | 2004-04-22 | Shannon Mark E. | Four human zinc-finger-containing proteins: MDZ3, MDZ4, MDZ7 and MDZ12 |
| CA2456229A1 (en) * | 2001-08-03 | 2003-02-13 | Diversa Corporation | Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| US6943001B2 (en) * | 2001-08-03 | 2005-09-13 | Diversa Corporation | Epoxide hydrolases, nucleic acids encoding them and methods for making and using them |
| US6987079B2 (en) * | 2001-08-14 | 2006-01-17 | W.R. Grace & Co.-Conn. | Supported catalyst systems |
| US7647184B2 (en) * | 2001-08-27 | 2010-01-12 | Hanall Pharmaceuticals, Co. Ltd | High throughput directed evolution by rational mutagenesis |
| MXPA04002817A (es) | 2001-09-27 | 2004-07-05 | Pioneer Hi Bred Int | Polinucleotidos de fitato y metodos de uso. |
| WO2003029456A1 (en) | 2001-10-01 | 2003-04-10 | Dyax Corp. | Multi-chain eukaryotic display vectors and uses thereof |
| NZ532027A (en) | 2001-10-10 | 2008-09-26 | Neose Technologies Inc | Remodeling and glycoconjugation of peptides |
| WO2003035842A2 (en) * | 2001-10-24 | 2003-05-01 | Dyax Corporation | Hybridization control of sequence variation |
| US7175983B2 (en) * | 2001-11-02 | 2007-02-13 | Abmaxis, Inc. | Adapter-directed display systems |
| DK1451322T3 (da) | 2001-11-05 | 2010-02-01 | Zymogenetics Inc | Il-21-antagonister |
| GB0126887D0 (en) * | 2001-11-08 | 2002-01-02 | Univ London | Method for producing and identifying soluble protein domains |
| US20110151438A9 (en) | 2001-11-19 | 2011-06-23 | Affymetrix, Inc. | Methods of Analysis of Methylation |
| CA2467460A1 (en) * | 2001-11-19 | 2003-05-30 | Parallele Bioscience, Inc. | Multiplex oligonucleotide addition and target amplification |
| US6768476B2 (en) * | 2001-12-05 | 2004-07-27 | Etenna Corporation | Capacitively-loaded bent-wire monopole on an artificial magnetic conductor |
| DE10162727A1 (de) | 2001-12-20 | 2003-07-10 | Henkel Kgaa | Neue Alkalische Protease aus Bacillus gibsonii (DSM 14391) und Wasch-und Reinigungsmittel enthaltend diese neue Alkalische Protease |
| DE10162728A1 (de) | 2001-12-20 | 2003-07-10 | Henkel Kgaa | Neue Alkalische Protease aus Bacillus gibsonii (DSM 14393) und Wasch-und Reinigungsmittel enthaltend diese neue Alkalische Protease |
| DE10163884A1 (de) | 2001-12-22 | 2003-07-10 | Henkel Kgaa | Neue Alkalische Protease aus Bacillus sp. (DSM 14392) und Wasch- und Reinigungsmittel enthaltend diese neue Alkalische Protease |
| US20040137547A1 (en) * | 2001-12-28 | 2004-07-15 | Medtronic Minimed, Inc. | Method for formulating a glucose oxidase enzyme with a desired property or properties and a glucose oxidase enzyme with the desired property |
| US20040009498A1 (en) * | 2002-01-14 | 2004-01-15 | Diversa Corporation | Chimeric antigen binding molecules and methods for making and using them |
| WO2003061570A2 (en) * | 2002-01-16 | 2003-07-31 | Zyomyx, Inc. | Engineered binding proteins |
| ES2546797T3 (es) | 2002-01-18 | 2015-09-28 | Zymogenetics, Inc. | Multímeros Zcytor17 receptores de citocinas |
| EP1476541B1 (en) | 2002-01-18 | 2008-07-16 | ZymoGenetics, Inc. | Cytokine (zcytor17 ligand) |
| US20040048311A1 (en) * | 2002-01-24 | 2004-03-11 | Dana Ault-Riche | Use of collections of binding sites for sample profiling and other applications |
| JP4472345B2 (ja) * | 2002-01-25 | 2010-06-02 | エヴォルヴァ・リミテッド | 複数パラメータースクリーニングおよび複数機能性小分子産生細胞への進化方法 |
| US20040096826A1 (en) * | 2002-01-30 | 2004-05-20 | Evans Glen A. | Methods for creating recombination products between nucleotide sequences |
| PL211693B1 (pl) | 2002-02-12 | 2012-06-29 | Pfizer Prod Inc | Gen Streptomyces Avermitilis kierujący stosunkiem awermektyn B2:B1 |
| ES2310237T3 (es) | 2002-02-21 | 2009-01-01 | Asm Scientific, Inc. | Amplificacion por recombinasa polimerasa. |
| US8030000B2 (en) | 2002-02-21 | 2011-10-04 | Alere San Diego, Inc. | Recombinase polymerase amplification |
| US7399590B2 (en) | 2002-02-21 | 2008-07-15 | Asm Scientific, Inc. | Recombinase polymerase amplification |
| ATE414142T1 (de) | 2002-02-22 | 2008-11-15 | Progenics Pharm Inc | Anti-ccr5 antikörper |
| AU2003217716A1 (en) * | 2002-02-25 | 2003-09-09 | Cabot Corporation | Custom ligand design for biomolecular filtration and purification for bioseperation |
| US20030224404A1 (en) * | 2002-02-25 | 2003-12-04 | Manuel Vega | High throughput directed evolution of nucleic acids by rational mutagenesis |
| EP1476563B1 (en) | 2002-02-26 | 2008-09-17 | E.I. Du Pont De Nemours And Company | Method for the recombination of genetic elements |
| WO2003072742A2 (en) | 2002-02-27 | 2003-09-04 | California Institute Of Technology | Novel glucose 6-oxidases |
| US20050084907A1 (en) | 2002-03-01 | 2005-04-21 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| US6977162B2 (en) * | 2002-03-01 | 2005-12-20 | Ravgen, Inc. | Rapid analysis of variations in a genome |
| WO2003075129A2 (en) | 2002-03-01 | 2003-09-12 | Maxygen, Inc. | Methods, systems, and software for identifying functional bio-molecules |
| IL163597A0 (en) * | 2002-03-01 | 2005-12-18 | Ravgen Inc | Rapid analysis of variations in a genome |
| US7747391B2 (en) * | 2002-03-01 | 2010-06-29 | Maxygen, Inc. | Methods, systems, and software for identifying functional biomolecules |
| WO2003078583A2 (en) | 2002-03-09 | 2003-09-25 | Maxygen, Inc. | Optimization of crossover points for directed evolution |
| US7176025B2 (en) * | 2002-03-11 | 2007-02-13 | Nugen Technologies, Inc. | Methods for generating double stranded DNA comprising a 3′ single stranded portion and uses of these complexes for recombination |
| CN100497378C (zh) | 2002-03-22 | 2009-06-10 | 拜尔生物科学公司 | 新的苏云金芽孢杆菌杀昆虫蛋白质 |
| EP1572927A4 (en) | 2002-04-08 | 2007-10-17 | Pioneer Hi Bred Int | REINFORCED EXTRACTION OF SILK UNDER STRESS |
| JP2005523014A (ja) * | 2002-04-16 | 2005-08-04 | プロメガ コーポレイション | 相同的組換えの増強方法 |
| US7226771B2 (en) | 2002-04-19 | 2007-06-05 | Diversa Corporation | Phospholipases, nucleic acids encoding them and methods for making and using them |
| CN1659274A (zh) | 2002-04-19 | 2005-08-24 | 津莫吉尼蒂克斯公司 | 细胞因子受体 |
| ES2395898T3 (es) | 2002-04-19 | 2013-02-15 | Dsm Ip Assets B.V. | Fosfolipasas, ácidos nucleicos que las codifican, y métodos para obtenerlas y usarlas |
| EP1501927A2 (en) * | 2002-05-02 | 2005-02-02 | University Of North Carolina At Chapel Hill | In vitro mutagenesis, phenotyping, and gene mapping |
| FR2839317A1 (fr) * | 2002-05-06 | 2003-11-07 | Entomed | Procede d'evolution fonctionnelle artificielle de sequences polynucleotidiques, polynucleotides recombines obtenus et peptides, polypeptides et proteines codes par ceux-ci |
| US7442506B2 (en) * | 2002-05-08 | 2008-10-28 | Ravgen, Inc. | Methods for detection of genetic disorders |
| US20070178478A1 (en) * | 2002-05-08 | 2007-08-02 | Dhallan Ravinder S | Methods for detection of genetic disorders |
| US7727720B2 (en) * | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
| GB2388604B (en) * | 2002-05-17 | 2005-01-26 | Alligator Bioscience Ab | A method for in vitro molecular evolution of protein function |
| DK1504098T4 (da) * | 2002-05-17 | 2011-05-23 | Alligator Bioscience Ab | Fremgangsmåde til molekyulær udvikling in vitro af proteinfunktion |
| CA2487133A1 (en) | 2002-06-07 | 2003-12-18 | Zymogenetics, Inc. | Use of il-21 in cancer and other therapeutic applications |
| GB0213816D0 (en) * | 2002-06-14 | 2002-07-24 | Univ Aston | Method of producing DNA and protein libraries |
| US20030232395A1 (en) * | 2002-06-14 | 2003-12-18 | Dyax Corporation | Recombination of nucleic acid library members |
| US9321832B2 (en) | 2002-06-28 | 2016-04-26 | Domantis Limited | Ligand |
| DE10233047A1 (de) * | 2002-07-19 | 2004-02-26 | Amaxa Gmbh | Verfahren zur Herstellung eines künstlichen Polypeptids und nach diesem Verfahren hergestelltes künstliches Protein |
| EP1527173A1 (en) * | 2002-07-23 | 2005-05-04 | Nuevolution A/S | Gene shuffing by template switching |
| WO2004011605A2 (en) | 2002-07-25 | 2004-02-05 | Mj Bioworks Incorporated | Hybrid protein methods and compositions |
| EP1529110B1 (en) * | 2002-08-01 | 2011-10-05 | Evolva Ltd. | Methods of mixing large numbers of heterologous genes |
| CA2494798A1 (en) | 2002-08-06 | 2005-01-13 | Verdia, Inc. | Ap1 amine oxidase variants |
| US7047591B2 (en) * | 2002-09-20 | 2006-05-23 | Colgate-Palmolive Company | Oral care implement |
| AU2003263552A1 (en) * | 2002-09-09 | 2004-03-29 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| US20050202438A1 (en) * | 2002-09-09 | 2005-09-15 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| US20060020396A1 (en) * | 2002-09-09 | 2006-01-26 | Rene Gantier | Rational directed protein evolution using two-dimensional rational mutagenesis scanning |
| US7563600B2 (en) | 2002-09-12 | 2009-07-21 | Combimatrix Corporation | Microarray synthesis and assembly of gene-length polynucleotides |
| CA2499552C (en) * | 2002-09-20 | 2010-11-16 | Colgate-Palmolive Company | Toothbrush with gripping area |
| AU2002951899A0 (en) * | 2002-10-04 | 2002-10-24 | Macquarie University | Random drift mutagenesis |
| JP3447009B1 (ja) * | 2002-10-29 | 2003-09-16 | 實 平垣 | 構築物用構成体およびその製造方法 |
| EP1576126A3 (en) * | 2002-10-30 | 2005-10-26 | Pointilliste, Inc. | Systems for capture and analysis of biological particles and methods using the systems |
| US7135290B2 (en) * | 2003-04-12 | 2006-11-14 | Solazyme, Inc. | Methods and compositions for evolving hydrogenase genes |
| US7090979B2 (en) * | 2002-11-22 | 2006-08-15 | The Regents Of The University Of California | Derivatized versions of ligase enzymes for constructing DNA sequences |
| DK1578964T4 (da) | 2002-12-20 | 2013-12-02 | Novozymes As | Polypeptider med cellobiohydrolase II-aktivitet og polynukleotider, der koder for samme |
| US7955814B2 (en) | 2003-01-17 | 2011-06-07 | Danisco A/S | Method |
| DE602004030000D1 (de) | 2003-01-17 | 2010-12-23 | Danisco | Verfahren zur in-situ-herstellung eines emulgators in einem nahrungsmittel |
| US20050196766A1 (en) | 2003-12-24 | 2005-09-08 | Soe Jorn B. | Proteins |
| ES2661213T3 (es) | 2003-01-17 | 2018-03-28 | Dupont Nutrition Biosciences Aps | Método para la producción in situ de un emulsionante en un producto alimenticio |
| EP1585752B1 (en) | 2003-01-21 | 2007-11-21 | Thallion Pharmaceuticals Inc. | Polyene polyketides, processes for their production and their use as a pharmaceutical |
| DE102004002243A1 (de) * | 2003-02-07 | 2004-09-16 | Trikon Technologies Limited, Newport | Elektrostatische Klemmhalterung für dünne Wafer in einer Vakuumkammer zur Plasmabearbeitung |
| US20040241748A1 (en) * | 2003-02-10 | 2004-12-02 | Dana Ault-Riche | Self-assembling arrays and uses thereof |
| EP2194133B1 (en) | 2003-03-06 | 2015-12-02 | BASF Enzymes LLC | Amylases, nucleic acids encoding them and methods for making and using them |
| JP4829105B2 (ja) | 2003-03-07 | 2011-12-07 | ヴェレニウム コーポレイション | ヒドロラーゼ、それをコードする核酸並びにその製造および使用方法 |
| US7083931B2 (en) | 2003-04-04 | 2006-08-01 | Stratagene California | Renilla GFP mutants with increased fluorescent intensity and spectral shift |
| PL1613733T3 (pl) | 2003-04-04 | 2015-11-30 | Basf Enzymes Llc | Liazy pektynianowe, kodujące je kwasy nukleinowe oraz sposoby ich wytwarzania i zastosowania |
| MXPA05010773A (es) | 2003-04-09 | 2005-12-12 | Neose Technologies Inc | Metodos de glicopegilacion y proteinas/peptidos producidos por los metodos. |
| US7402386B2 (en) | 2003-04-14 | 2008-07-22 | Nugen Technologies, Inc. | Global amplification using random priming by a composite primer |
| HRP20050930A2 (en) | 2003-04-29 | 2006-03-31 | E. I. du Pont de Nemours and Company Pioneer Hi-Bred International Verdia | Novel glyphosate-n-acetyltransferase (gat) genes |
| EP1628680B1 (en) | 2003-05-15 | 2012-10-24 | Novartis Vaccines and Diagnostics, Inc. | Hiv polynucleotides and polypeptides derived from botswana mj4 |
| US7524664B2 (en) | 2003-06-17 | 2009-04-28 | California Institute Of Technology | Regio- and enantioselective alkane hydroxylation with modified cytochrome P450 |
| WO2005017106A2 (en) | 2003-06-17 | 2005-02-24 | California Institute Of Technology | Libraries of optimized cytochrome p450 enzymes and the optimized p450 enzymes |
| US20050048578A1 (en) * | 2003-06-26 | 2005-03-03 | Epitomics, Inc. | Methods of screening for monoclonal antibodies with desirable activity |
| EP2404931A1 (en) | 2003-07-02 | 2012-01-11 | Verenium Corporation | Glucanases, nucleic acids encoding them and methods for making and using them |
| EP1660646B1 (en) | 2003-08-11 | 2014-12-31 | California Institute Of Technology | Thermostable peroxide-driven cytochrome p450 oxygenase variants and methods of use |
| US7741089B2 (en) | 2003-08-11 | 2010-06-22 | Verenium Corporation | Laccases, nucleic acids encoding them and methods for making and using them |
| AU2004266199B2 (en) | 2003-08-25 | 2010-09-16 | Amyra Biotech Ag | Novel fungal proteins and nucleic acids encoding same |
| DE602004032042D1 (de) * | 2003-08-27 | 2011-05-12 | Proterec Ltd | Bibliotheken rekombinanter chimärischer proteine |
| US20070149496A1 (en) * | 2003-10-31 | 2007-06-28 | Jack Tuszynski | Water-soluble compound |
| US7906307B2 (en) | 2003-12-24 | 2011-03-15 | Danisco A/S | Variant lipid acyltransferases and methods of making |
| AU2004312215B2 (en) | 2003-12-24 | 2009-03-05 | Dupont Nutrition Biosciences Aps | Proteins |
| US7718408B2 (en) | 2003-12-24 | 2010-05-18 | Danisco A/S | Method |
| GB0716126D0 (en) | 2007-08-17 | 2007-09-26 | Danisco | Process |
| ES2552053T3 (es) | 2004-02-25 | 2015-11-25 | Pioneer Hi-Bred International Inc. | Nuevos polipéptidos cristalinos de Bacillus thuringiensis, polinucleótidos, y composiciones de los mismos |
| EP1718742B1 (en) | 2004-02-25 | 2014-12-24 | Novozymes A/S | Fungal cell wall degrading enzyme |
| GB0405637D0 (en) | 2004-03-12 | 2004-04-21 | Danisco | Protein |
| US7622125B2 (en) * | 2004-05-05 | 2009-11-24 | Novartis Vaccines And Diagnostics, Inc. | Polycistronic HIV vector constructs |
| EP3985125A1 (en) * | 2004-06-01 | 2022-04-20 | Abbott Diagnostics Scarborough, Inc. | Recombinase polymerase amplification |
| AU2015203225B2 (en) * | 2004-06-01 | 2017-05-04 | Abbott Diagnostics Scarborough, Inc. | Recombinase Polymerase Amplification |
| CA2734561A1 (en) | 2004-06-09 | 2005-12-29 | Pioneer Hi-Bred International, Inc. | Plastid transit peptides |
| WO2005123956A2 (en) * | 2004-06-09 | 2005-12-29 | Wisconsin Alumni Research Foundation | Rapid production of oligonucleotides |
| EA013993B1 (ru) | 2004-06-16 | 2010-08-30 | Верениум Корпорейшн | Композиции для ферментативного обесцвечивания хлорофилла и способы |
| PL1776455T3 (pl) | 2004-07-16 | 2015-09-30 | Dupont Nutrition Biosci Aps | Enzym lipolityczny, jego zastosowania w przemyśle spożywczym |
| GB0421598D0 (en) | 2004-09-29 | 2004-10-27 | Cambridge Advanced Tech | Modification of plant development and morphology |
| CA2584984A1 (en) * | 2004-10-18 | 2006-04-27 | Codon Devices, Inc. | Methods for assembly of high fidelity synthetic polynucleotides |
| US20060204979A1 (en) * | 2004-12-01 | 2006-09-14 | Invitrogen Corporation | Reverse two-hybrid system for identification of interaction domains |
| DE102005005438A1 (de) * | 2005-02-05 | 2006-08-24 | Bayer Healthcare Ag | Mutanten des fluoreszierenden Proteins CGFPs, sowie deren Verwendung |
| EP1856156A2 (en) | 2005-02-08 | 2007-11-21 | ZymoGenetics, Inc. | Anti-il-20, anti-il-22 and anti-il-22ra antibodies and binding partners and methods of using in inflammation |
| CA2614769A1 (en) | 2005-03-10 | 2006-09-21 | Verenium Corporation | Lyase enzymes, nucleic acids encoding them and methods for making and using them |
| CA2611859C (en) | 2005-03-15 | 2015-03-31 | Verenium Corporation | Cellulases, nucleic acids encoding them and methods for making and using them |
| US11214817B2 (en) | 2005-03-28 | 2022-01-04 | California Institute Of Technology | Alkane oxidation by modified hydroxylases |
| US8715988B2 (en) | 2005-03-28 | 2014-05-06 | California Institute Of Technology | Alkane oxidation by modified hydroxylases |
| US20070009928A1 (en) * | 2005-03-31 | 2007-01-11 | Lathrop Richard H | Gene synthesis using pooled DNA |
| US8076108B2 (en) * | 2005-04-26 | 2011-12-13 | Cargill, Incorporated | Polypeptides and biosynthetic pathways for the production of stereoisomers of monatin and their precursors |
| ES2609429T3 (es) | 2005-05-12 | 2017-04-20 | Zymogenetics, Inc. | Composiciones y métodos para modular respuestas inmunitarias |
| MX2007016032A (es) | 2005-06-21 | 2008-03-10 | Xoma Technology Ltd | Anticuerpos de enlace a il-1-beta y fragmentos de los mismos. |
| EP2385140B1 (en) | 2005-07-25 | 2014-07-16 | Alere San Diego, Inc. | Methods for multiplexing recombinase polymerase amplification |
| US7939258B2 (en) * | 2005-09-07 | 2011-05-10 | Nugen Technologies, Inc. | Nucleic acid amplification procedure using RNA and DNA composite primers |
| AU2006318652A1 (en) * | 2005-11-18 | 2007-05-31 | Gloucester Pharmaceuticals, Inc. | Metabolite derivatives of the HDAC inhibitor FK228 |
| GB2432366B (en) * | 2005-11-19 | 2007-11-21 | Alligator Bioscience Ab | A method for in vitro molecular evolution of protein function |
| EP1973937B1 (en) * | 2006-01-11 | 2011-05-25 | Axxam S.P.A. | Luminescent transgenic non human animals, progeny, cell derivatives and uses thereof |
| WO2007092314A2 (en) | 2006-02-02 | 2007-08-16 | Verenium Corporation | Esterases and related nucleic acids and methods |
| CA2637013A1 (en) | 2006-02-10 | 2007-08-23 | Verenium Corporation | Cellulolytic enzymes, nucleic acids encoding them and methods for making and using them |
| BRPI0707784B1 (pt) | 2006-02-14 | 2018-05-22 | Verenium Corporation | Ácido nucléico isolado, sintético ou recombinante, cassete de expressão, vetor ou veículo de clonagem, célula hospedeira isolada transformada, e método para produção de um polipeptídeo recombinante |
| ES2383767T3 (es) | 2006-03-07 | 2012-06-26 | Verenium Corporation | Aldolasas, ácidos nucleicos que las codifican y métodos para producir y usar las mismas |
| WO2007103389A2 (en) | 2006-03-07 | 2007-09-13 | Cargill, Incorporated | Aldolases, nucleic acids encoding them and methods for making and using them |
| US20070231805A1 (en) * | 2006-03-31 | 2007-10-04 | Baynes Brian M | Nucleic acid assembly optimization using clamped mismatch binding proteins |
| CA2649877A1 (en) * | 2006-04-24 | 2007-12-21 | Gloucester Pharmaceuticals | Gemcitabine combination therapy |
| JP2009535053A (ja) | 2006-05-04 | 2009-10-01 | エーエスエム サイエンティフィック, インコーポレイテッド | レコンビナーゼポリメラーゼ増幅 |
| WO2007137163A2 (en) | 2006-05-19 | 2007-11-29 | Georgia Tech Research Corporation | Abc transporter ligand |
| WO2007146730A2 (en) | 2006-06-08 | 2007-12-21 | Gloucester Pharmaceuticals | Deacetylase inhibitor therapy |
| US7572618B2 (en) | 2006-06-30 | 2009-08-11 | Bristol-Myers Squibb Company | Polynucleotides encoding novel PCSK9 variants |
| WO2008008873A2 (en) | 2006-07-14 | 2008-01-17 | Georgia Tech Research Corporation | Clc channel ligand |
| US8252559B2 (en) | 2006-08-04 | 2012-08-28 | The California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
| US8026085B2 (en) | 2006-08-04 | 2011-09-27 | California Institute Of Technology | Methods and systems for selective fluorination of organic molecules |
| EP2444413A1 (en) | 2006-08-04 | 2012-04-25 | Verenium Corporation | Methods for oil or gas well drilling, washing and/or fracturing |
| US8053191B2 (en) | 2006-08-31 | 2011-11-08 | Westend Asset Clearinghouse Company, Llc | Iterative nucleic acid assembly using activation of vector-encoded traits |
| MX2009003034A (es) | 2006-09-21 | 2009-11-18 | Verenium Corp | Fosfolipasas, acidos nucleicos que las codifican, y metodos de hacerlas y usarlas. |
| EP2617822A3 (en) | 2006-09-21 | 2013-10-16 | Verenium Corporation | Phytases, nucleic acids encoding them and methods for making and using them |
| CN101578370B (zh) | 2006-12-20 | 2015-11-25 | 孟山都巴西有限公司 | 编码c3hc4家族植物蛋白质的核酸分子和改变植物纤维素和木素含量的方法 |
| BRPI0720468A2 (pt) | 2006-12-20 | 2014-01-14 | Alellyx Sa | Construtos de ácido nucleico e métodos para alterar o comprimento da fibra da planta e/ou a altura da planta |
| ES2531167T5 (es) | 2006-12-21 | 2018-05-21 | Basf Enzymes Llc | Amilasas y glucoamilasas, ácidos nucleicos que las codifican y métodos para formarlas y utilizarlas |
| BRPI0720991A8 (pt) * | 2006-12-29 | 2016-03-15 | Gloucester Pharmaceuticals Inc | Preparação da romidepsina |
| AU2007342030B2 (en) * | 2006-12-29 | 2013-08-15 | Celgene Corporation | Romidepsin-based treatments for cancer |
| DE102007003143A1 (de) | 2007-01-16 | 2008-07-17 | Henkel Kgaa | Neue Alkalische Protease aus Bacillus gibsonii und Wasch- und Reinigungsmittel enthaltend diese neue Alkalische Protease |
| AU2007344910B2 (en) | 2007-01-25 | 2013-03-28 | Dupont Nutrition Biosciences Aps | Production of a lipid acyltransferase from transformed Bacillus licheniformis cells |
| NZ610301A (en) | 2007-01-30 | 2015-03-27 | Bp Corp North America Inc | Enzymes for the treatment of lignocellulosics, nucleic acids encoding them and methods for making and using them |
| WO2009008908A2 (en) | 2007-02-12 | 2009-01-15 | Codexis, Inc. | Structure-activity relationships |
| EP2124988B1 (en) | 2007-02-23 | 2014-11-12 | The Trustees of Columbia University in the City of New York | Methods to activate or block the hla-e/qa-1 restricted cd8+ t cell regulatory pathway to treat immunological disease |
| US7883879B2 (en) | 2007-10-01 | 2011-02-08 | Codexis, Inc. | Ketoreductase polypeptides for the production of azetidinone |
| US8486680B2 (en) | 2007-10-03 | 2013-07-16 | Bp Corporation North America Inc. | Xylanases, nucleic acids encoding them and methods for making and using them |
| AU2008308509B2 (en) | 2007-10-04 | 2014-10-23 | Zymogenetics, Inc. | B7 family member zB7H6 and related compositions and methods |
| DE102007051092A1 (de) | 2007-10-24 | 2009-04-30 | Henkel Ag & Co. Kgaa | Subtilisin aus Becillus pumilus und Wasch- und Reinigungsmittel enthaltend dieses neue Subtilisin |
| CN101998965B (zh) | 2007-11-01 | 2014-03-12 | 安斯泰来制药有限公司 | 免疫抑制性多肽与核酸 |
| WO2009059379A1 (en) | 2007-11-07 | 2009-05-14 | Dynamic Microbials Limited | Antimicrobial compositions, formulations and uses thereof |
| MX2010005565A (es) | 2007-11-20 | 2010-06-11 | Pioneer Hi Bred Int | Genes de señalizacion de etileno en maiz y su modulacion para mejor tolerancia al estres en plantas. |
| WO2009065415A1 (en) | 2007-11-21 | 2009-05-28 | Roskilde Universitet | Polypeptides comprising an ice-binding activity |
| WO2009065934A1 (en) * | 2007-11-22 | 2009-05-28 | Novozymes A/S | Polypeptides having ferulic acid esterase activity and polynucleotides encoding same |
| NZ585870A (en) | 2007-12-21 | 2012-04-27 | Danisco | Process for edible oil refining using a lipid acyltransferase |
| CA2710922A1 (en) | 2008-01-03 | 2009-07-16 | Verenium Corporation | Isomerases, nucleic acids encoding them and methods for making and using them |
| US8709772B2 (en) | 2008-01-03 | 2014-04-29 | Verenium Corporation | Transferases and oxidoreductases, nucleic acids encoding them and methods for making and using them |
| BRPI0907640A2 (pt) | 2008-01-25 | 2015-11-03 | Univ Aarhus | inibição exosítio-seletiva da atividade de papp-a contra igfbp-4 |
| WO2009102901A1 (en) | 2008-02-12 | 2009-08-20 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
| US8034568B2 (en) * | 2008-02-12 | 2011-10-11 | Nugen Technologies, Inc. | Isothermal nucleic acid amplification methods and compositions |
| US8504498B2 (en) | 2008-02-12 | 2013-08-06 | Codexis, Inc. | Method of generating an optimized, diverse population of variants |
| GB2470672B (en) | 2008-03-21 | 2012-09-12 | Nugen Technologies Inc | Methods of RNA amplification in the presence of DNA |
| CN102066409A (zh) | 2008-04-17 | 2011-05-18 | 诺维信公司 | 具有阿魏酸酯酶活性的多肽和编码该多肽的多核苷酸 |
| GB0807161D0 (en) * | 2008-04-18 | 2008-05-21 | Danisco | Process |
| CA2990650C (en) | 2008-05-23 | 2021-02-09 | Pioneer Hi-Bred International, Inc. | Novel dgat genes for increased seed storage lipid production and altered fatty acid profiles in oilseed plants |
| US8383346B2 (en) | 2008-06-13 | 2013-02-26 | Codexis, Inc. | Combined automated parallel synthesis of polynucleotide variants |
| CN102131813B (zh) | 2008-06-24 | 2014-07-30 | 科德克希思公司 | 用于制备基本上立体异构纯的稠合二环脯氨酸化合物的生物催化方法 |
| US8426178B2 (en) * | 2008-08-27 | 2013-04-23 | Codexis, Inc. | Ketoreductase polypeptides for the production of a 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
| US8288141B2 (en) * | 2008-08-27 | 2012-10-16 | Codexis, Inc. | Ketoreductase polypeptides for the production of 3-aryl-3-hydroxypropanamine from a 3-aryl-3-ketopropanamine |
| WO2010027710A2 (en) | 2008-08-27 | 2010-03-11 | Codexis, Inc. | Ketoreductase polypeptides and uses thereof |
| WO2010025085A2 (en) | 2008-08-29 | 2010-03-04 | Codexis, Inc. | Ketoreductase polypeptides for the stereoselective production of (4s)-3[(5s)-5(4-fluorophenyl)-5-hydroxypentanoyl]-4-phenyl-1,3-oxazolidin-2-one |
| US8198062B2 (en) | 2008-08-29 | 2012-06-12 | Dsm Ip Assets B.V. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| US8153391B2 (en) | 2008-08-29 | 2012-04-10 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| US8357503B2 (en) | 2008-08-29 | 2013-01-22 | Bunge Oils, Inc. | Hydrolases, nucleic acids encoding them and methods for making and using them |
| US20100081575A1 (en) * | 2008-09-22 | 2010-04-01 | Robert Anthony Williamson | Methods for creating diversity in libraries and libraries, display vectors and methods, and displayed molecules |
| DK2346995T3 (en) | 2008-09-26 | 2019-02-11 | Tocagen Inc | GENETERIVE VECTORS AND CYTOSINDEAMINASES |
| AU2009313560B2 (en) | 2008-11-07 | 2016-04-14 | Fabrus Llc | Combinatorial antibody libraries and uses thereof |
| US8247192B2 (en) * | 2008-11-10 | 2012-08-21 | Codexis, Inc. | Penicillin-G acylases |
| JP5645840B2 (ja) | 2008-12-02 | 2014-12-24 | 株式会社Wave Life Sciences Japan | リン原子修飾核酸の合成方法 |
| EP2789618B1 (en) | 2008-12-03 | 2016-07-27 | The Scripps Research Institute | Stem cell cultures |
| WO2010065867A1 (en) | 2008-12-04 | 2010-06-10 | Pioneer Hi-Bred International, Inc. | Methods and compositions for enhanced yield by targeted expression of knotted1 |
| US8187856B2 (en) * | 2008-12-18 | 2012-05-29 | Codexis, Inc. | Recombinant halohydrin dehalogenase polypeptides |
| SG172783A1 (en) | 2008-12-25 | 2011-08-29 | Codexis Inc | Enone reductases |
| US20120034650A1 (en) | 2009-02-13 | 2012-02-09 | Novartis Ag | Nucleic acid molecule of a biosynthetic cluster encoding non ribosomal peptide synthases and uses thereof |
| US8715996B2 (en) | 2009-02-26 | 2014-05-06 | Codexis, Inc. | Beta-glucosidase variant enzymes and related polynucleotides |
| WO2010099501A2 (en) | 2009-02-26 | 2010-09-02 | Codexis, Inc. | Transaminase biocatalysts |
| WO2010101818A1 (en) | 2009-03-02 | 2010-09-10 | Pioneer Hi-Bred International, Inc. | Nac transcriptional activators involved in abiotic stress tolerance |
| EP2408908B1 (en) | 2009-03-17 | 2015-05-27 | Codexis, Inc. | Variant endoglucanases and related polynucleotides |
| MX2011010097A (es) | 2009-03-27 | 2011-10-19 | Proyecto Biomedicina Cima Sl | Metodos y composiciones para el tratamiento de cirrosis y fibrosis hepatica. |
| WO2010120557A1 (en) | 2009-03-31 | 2010-10-21 | Codexis, Inc. | Improved endoglucanases |
| US20120058222A1 (en) | 2009-05-19 | 2012-03-08 | Danisco A/S | Use |
| WO2010135310A1 (en) | 2009-05-20 | 2010-11-25 | Biosite Incorporated | Dna glycosylase/lyase and ap endonuclease substrates |
| CA2763283C (en) | 2009-05-21 | 2021-01-12 | Verenium Corporation | Phytases, nucleic acids encoding them and methods for making and using them |
| WO2010141940A1 (en) | 2009-06-05 | 2010-12-09 | Alere San Diego, Inc. | Recombinase polymerase amplification reagents and kits |
| AR077042A1 (es) | 2009-06-12 | 2011-07-27 | Danisco | Metodo para tratar una composicion que contiene pirofiofitina |
| CA2765715A1 (en) | 2009-06-16 | 2010-12-23 | Codexis, Inc. | .beta.-glucosidase variants |
| CN102597226B (zh) | 2009-06-22 | 2015-08-19 | 科德克希思公司 | 转氨酶反应 |
| DK3409765T3 (da) | 2009-06-22 | 2021-09-27 | Codexis Inc | Ketoreduktase-medieret stereoselektiv rute til alpha-chloralkoholer |
| IN2012DN00720A (enExample) | 2009-07-06 | 2015-06-19 | Ontorii Inc | |
| US8614081B2 (en) | 2009-07-23 | 2013-12-24 | Codexis, Inc. | Nitrilase biocatalysts |
| WO2011017492A2 (en) | 2009-08-05 | 2011-02-10 | Pioneer Hi-Bred International, Inc. | Novel eto1 genes and use of same for reduced ethylene and improved stress tolerance in plants |
| SG10201405022PA (en) | 2009-08-19 | 2014-10-30 | Codexis Inc | Ketoreductase polypeptides for the preparation of phenylephrine |
| EP2467395A1 (en) | 2009-08-20 | 2012-06-27 | Pioneer Hi-Bred International Inc. | Functional expression of shuffled yeast nitrate transporter (ynti) in maize to improve nitrate uptake under low nitrate environment |
| US8785170B2 (en) | 2009-09-04 | 2014-07-22 | Codexis, Inc. | Variant CBH2 cellulases and related polynucleotides |
| WO2011041594A1 (en) | 2009-09-30 | 2011-04-07 | Codexis, Inc. | Recombinant c1 b-glucosidase for production of sugars from cellulosic biomass |
| UA109884C2 (uk) | 2009-10-16 | 2015-10-26 | Поліпептид, що має активність ферменту фосфатидилінозитол-специфічної фосфоліпази с, нуклеїнова кислота, що його кодує, та спосіб його виробництва і застосування | |
| UA111708C2 (uk) | 2009-10-16 | 2016-06-10 | Бандж Ойлз, Інк. | Спосіб рафінування олії |
| US10207240B2 (en) | 2009-11-03 | 2019-02-19 | Gen9, Inc. | Methods and microfluidic devices for the manipulation of droplets in high fidelity polynucleotide assembly |
| GB0920089D0 (en) | 2009-11-17 | 2009-12-30 | Danisco | Method |
| CA2780974C (en) | 2009-11-20 | 2016-02-02 | Codexis, Inc. | Mutli-cellulase enzyme compositions for hydrolysis of cellulosic biomass |
| US9216414B2 (en) | 2009-11-25 | 2015-12-22 | Gen9, Inc. | Microfluidic devices and methods for gene synthesis |
| EP2706119B1 (en) | 2009-11-25 | 2015-08-12 | Codexis, Inc. | Recombinant beta-glucosidase variants for production of soluble sugars from cellulosic biomass |
| EP2510089B1 (en) | 2009-12-08 | 2015-10-21 | Codexis, Inc. | Synthesis of prazole compounds |
| US9217144B2 (en) | 2010-01-07 | 2015-12-22 | Gen9, Inc. | Assembly of high fidelity polynucleotides |
| WO2011100265A2 (en) | 2010-02-10 | 2011-08-18 | Codexis, Inc. | Processes using amino acid dehydrogenases and ketoreductase-based cofactor regenerating system |
| PL2545150T3 (pl) | 2010-03-12 | 2019-01-31 | Dupont Nutrition Biosciences Aps | Sposób |
| WO2011114251A1 (en) | 2010-03-18 | 2011-09-22 | Danisco A/S | Foodstuff |
| WO2011123567A1 (en) | 2010-03-31 | 2011-10-06 | Codexis, Inc. | Production of geranyl diphosphate |
| WO2011140219A1 (en) | 2010-05-04 | 2011-11-10 | Codexis, Inc. | Biocatalysts for ezetimibe synthesis |
| EP2569426A4 (en) | 2010-05-14 | 2013-10-09 | Codexis Inc | ZELLBIOHYDROLASE VARIANTS |
| CA2798937A1 (en) | 2010-05-28 | 2011-12-01 | Codexis, Inc. | Pentose fermentation by a recombinant microorganism |
| EP2580238A1 (en) | 2010-06-09 | 2013-04-17 | Zymogenetics, Inc. | Dimeric vstm3 fusion proteins and related compositions and methods |
| EP2582809A1 (en) | 2010-06-17 | 2013-04-24 | DuPont Nutrition Biosciences ApS | Process |
| SG10201505475XA (en) | 2010-07-12 | 2015-09-29 | Celgene Corp | Romidepsin solid forms and uses thereof |
| WO2012021794A1 (en) | 2010-08-13 | 2012-02-16 | Pioneer Hi-Bred International, Inc. | Chimeric promoters and methods of use |
| EP2606139B1 (en) | 2010-08-16 | 2015-07-15 | Codexis, Inc. | Biocatalysts and methods for the synthesis of (1r,2r)-2-(3,4-dimethoxyphenethoxy)cyclohexanamine |
| BR112013003906A2 (pt) | 2010-08-20 | 2018-07-17 | Codexis Inc | uso de proteínas da família glicosideo hidrolase no processamento de celulose. |
| US9322027B2 (en) | 2010-08-20 | 2016-04-26 | Shell Oil Company | Expression constructs comprising fungal promoters |
| US8859502B2 (en) | 2010-09-13 | 2014-10-14 | Celgene Corporation | Therapy for MLL-rearranged leukemia |
| US10428019B2 (en) | 2010-09-24 | 2019-10-01 | Wave Life Sciences Ltd. | Chiral auxiliaries |
| EP2625269A2 (en) | 2010-10-06 | 2013-08-14 | BP Corporation North America Inc. | Variant cbh i polypeptides with reduced product inhibition |
| US20130344541A1 (en) | 2010-11-02 | 2013-12-26 | Codexis, Inc. | Compositions and methods for production of fermentable sugars |
| US9068235B2 (en) | 2010-11-02 | 2015-06-30 | Codexis, Inc. | Fungal strains |
| WO2012064975A1 (en) | 2010-11-12 | 2012-05-18 | Gen9, Inc. | Protein arrays and methods of using and making the same |
| CN103502448B (zh) | 2010-11-12 | 2017-03-29 | Gen9股份有限公司 | 核酸合成的方法和设备 |
| WO2012078800A2 (en) | 2010-12-08 | 2012-06-14 | Codexis, Inc. | Biocatalysts and methods for the synthesis of armodafinil |
| US8906689B2 (en) | 2010-12-21 | 2014-12-09 | Codexis, Inc. | Endoglucanase variants |
| WO2012106579A1 (en) | 2011-02-03 | 2012-08-09 | Bristol-Myers Squibb Company | Amino acid dehydrogenase and its use in preparing amino acids from keto acids |
| CA2825628A1 (en) | 2011-02-23 | 2012-08-30 | Dupont Nutrition Biosciences Aps | Method |
| US9493749B2 (en) | 2011-02-23 | 2016-11-15 | Dupont Nutrition Biosciences Aps | Process modifications to enhance chlorophyll degradation |
| AR085251A1 (es) | 2011-02-23 | 2013-09-18 | Danisco | Proceso para tratar aceite vegetal |
| EP2691517A4 (en) | 2011-03-30 | 2015-04-22 | Codexis Inc | FERMENTATION OF PENTOSES BY A RECOMBINANT MICROORGANISM |
| ES2905686T3 (es) | 2011-04-07 | 2022-04-11 | Abbott Diagnostics Scarborough Inc | Control de mezclas de amplificación de recombinasa polimerasa |
| CA2830579A1 (en) | 2011-04-08 | 2012-10-11 | Danisco Us Inc. | Compositions |
| WO2012142302A2 (en) | 2011-04-13 | 2012-10-18 | Codexis, Inc. | Biocatalytic process for preparing eslicarbazepine and analogs thereof |
| BR112013033614A2 (pt) | 2011-06-30 | 2018-05-29 | Codexis Inc | fermentação de pentose por microorganismo recombinante |
| RU2014105311A (ru) | 2011-07-19 | 2015-08-27 | Уэйв Лайф Сайенсес Пте. Лтд. | Способы синтеза функционализованных нуклеиновых кислот |
| US9322007B2 (en) | 2011-07-22 | 2016-04-26 | The California Institute Of Technology | Stable fungal Cel6 enzyme variants |
| EP2748317B1 (en) | 2011-08-22 | 2017-04-19 | Codexis, Inc. | Gh61 glycoside hydrolase protein variants and cofactors that enhance gh61 activity |
| EP2748187A4 (en) | 2011-08-23 | 2015-03-04 | Codexis Inc | VARIANTS OF CELLOBIOHYDROLASE |
| EP3594340B1 (en) | 2011-08-26 | 2021-06-30 | Gen9, Inc. | Compositions and methods for high fidelity assembly of nucleic acids |
| US9109209B2 (en) | 2011-09-08 | 2015-08-18 | Codexis, Inc. | Biocatalysts and methods for the synthesis of substituted lactams |
| EP2760997A4 (en) | 2011-09-30 | 2015-02-11 | Codexis Inc | MUSHROOM PROTEASE |
| CN103906835A (zh) | 2011-10-25 | 2014-07-02 | 先锋国际良种公司 | 改变植物细胞壁组成以改善生物燃料生产和青贮饲料可消化性的方法 |
| CN109897103B (zh) | 2011-11-04 | 2024-05-17 | 酵活英属哥伦比亚有限公司 | 在Fc结构域中具有突变的稳定异源二聚的抗体设计 |
| CN104053771B (zh) | 2011-11-18 | 2016-11-09 | 科德克希思公司 | 用于制备羟基取代的氨基甲酸酯的生物催化剂 |
| WO2013096082A1 (en) | 2011-12-20 | 2013-06-27 | Codexis, Inc. | Fatty alcohol forming acyl reductase (far) variants and methods of use |
| US9611462B2 (en) | 2011-12-20 | 2017-04-04 | Codexis, Inc. | Endoglucanase 1B (EG1B) variants |
| WO2013104659A2 (en) | 2012-01-13 | 2013-07-18 | Dupont Nutrition Biosciences Aps | Process |
| WO2013104660A1 (en) | 2012-01-13 | 2013-07-18 | Dupont Nutrition Biosciences Aps | Process for treating a plant oil comprising hydrolysing chlorophyll or a chlorophyll derivative and involving partial caustic neutralisation |
| EP2825647A4 (en) * | 2012-03-15 | 2015-10-14 | Codexis Inc | METHODS OF GENE REARRANGING |
| US9150853B2 (en) | 2012-03-21 | 2015-10-06 | Gen9, Inc. | Methods for screening proteins using DNA encoded chemical libraries as templates for enzyme catalysis |
| SG11201405990PA (en) | 2012-03-23 | 2014-11-27 | Codexis Inc | Biocatalysts and methods for synthesizing derivatives of tryptamine and tryptamine analogs |
| US20150133698A1 (en) | 2012-04-20 | 2015-05-14 | Codexis, Inc. | Production of fatty alcohols from engineered microorganisms |
| EP3543350B1 (en) | 2012-04-24 | 2021-11-10 | Gen9, Inc. | Methods for sorting nucleic acids and multiplexed preparative in vitro cloning |
| WO2013160372A1 (en) | 2012-04-27 | 2013-10-31 | Dupont Nutrition Biosciences Aps | Process for treating plant oil involving addition of serial doses of chlorophyll or chlorophyll derivative degrading enzyme |
| WO2013160374A1 (en) | 2012-04-27 | 2013-10-31 | Dupont Nutrition Biosciences Aps | Process for refining crude plant oil involving enzymatic hydrolysis and gum recycling |
| RU2014148769A (ru) | 2012-05-04 | 2016-06-27 | Е.И. Дюпон Де Немур Энд Компани | Композиции и способы, включающие последовательности, характеризующиеся мегануклеазной активностью |
| SG11201407295YA (en) | 2012-05-08 | 2014-12-30 | Codexis Inc | Biocatalysts and methods for hydroxylation of chemical compounds |
| WO2013170050A1 (en) | 2012-05-11 | 2013-11-14 | Codexis, Inc. | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
| US10045499B2 (en) | 2012-05-24 | 2018-08-14 | Iowa State University Research Foundation, Inc. | Arabidopsis nonhost resistance gene(s) and use thereof to engineer disease resistant plants |
| US8980578B2 (en) | 2012-06-11 | 2015-03-17 | Codexis, Inc. | Fungal beta-xylosidase variants |
| CA2877823A1 (en) | 2012-06-25 | 2014-01-03 | Gen9, Inc. | Methods for nucleic acid assembly and high throughput sequencing |
| SG11201500232UA (en) | 2012-07-13 | 2015-04-29 | Wave Life Sciences Pte Ltd | Chiral control |
| SG11201500239VA (en) | 2012-07-13 | 2015-03-30 | Wave Life Sciences Japan | Asymmetric auxiliary group |
| CA2879066C (en) | 2012-07-13 | 2019-08-13 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant |
| WO2014015278A1 (en) | 2012-07-20 | 2014-01-23 | Codexis, Inc. | Production of fatty alcohols from engineered microorganisms |
| US9506087B2 (en) | 2012-08-07 | 2016-11-29 | Codexis, Inc. | Glucose and xylose co-utilization in E. coli |
| AU2013302535B2 (en) | 2012-08-16 | 2018-12-06 | Bangladesh Jute Research Institute | Pectin degrading enzymes from Macrophomina phaseolina and uses thereof |
| PT2885406T (pt) | 2012-08-16 | 2018-11-16 | Bangladesh Jute Res Institute | Enzimas degradantes de celulose e/ou hemiceluloses de macrophomina phaseolina e utilizações das mesmas |
| AU2013202506B2 (en) | 2012-09-07 | 2015-06-18 | Celgene Corporation | Resistance biomarkers for hdac inhibitors |
| WO2014063097A1 (en) | 2012-10-19 | 2014-04-24 | Danisco Us Inc. | Stabilization of biomimetic membranes |
| US9663532B2 (en) | 2012-10-29 | 2017-05-30 | University Of Rochester | Artemisinin derivatives, methods for their preparation and their use as antimalarial agents |
| AU2013202507B9 (en) | 2012-11-14 | 2015-08-13 | Celgene Corporation | Inhibition of drug resistant cancer cells |
| BR112015011466A8 (pt) | 2012-11-20 | 2018-05-02 | Codexis Inc | Célula hospedeira fúngica recombinante, constructo de ácido nucleico recombinante, sequência de polpeptídeo isolada, e, métodos para produzir um produto de fermentação e pelo menos um produto final a partir de pelo menos um substrato celulósico |
| CN104837994A (zh) * | 2012-12-06 | 2015-08-12 | 安捷伦科技有限公司 | 分子制造 |
| WO2014093070A1 (en) | 2012-12-14 | 2014-06-19 | Codexis, Inc. | Modified native beta-ketoacyl-acp synthases and engineered microorganisms |
| CN120829884A (zh) | 2012-12-21 | 2025-10-24 | 科德克希思公司 | 用于合成手性胺的工程化的生物催化剂和方法 |
| EP2946006B1 (en) | 2013-01-18 | 2019-04-10 | Codexis, Inc. | Engineered biocatalysts useful for carbapenem synthesis |
| KR20150113166A (ko) | 2013-01-31 | 2015-10-07 | 코덱시스, 인코포레이티드 | 상호작용 성분을 이용하여 생체분자를 확인하기 위한 방법, 시스템, 및 소프트웨어 |
| US20140288097A1 (en) | 2013-02-07 | 2014-09-25 | The Regents Of The University Of California | Use of translational profiling to identify target molecules for therapeutic treatment |
| SI2961844T1 (sl) | 2013-02-28 | 2018-11-30 | Codexis, Inc. | Spremenjeni polipeptidi transaminaze za industrijsko biokatalizo |
| GB201308828D0 (en) | 2013-03-12 | 2013-07-03 | Verenium Corp | Phytase |
| US20140289906A1 (en) | 2013-03-14 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Compositions Having Dicamba Decarboxylase Activity and Methods of Use |
| WO2014153242A1 (en) | 2013-03-14 | 2014-09-25 | Pioneer Hi-Bred International, Inc. | Compositions having dicamba decarboxylase activity and methods of use |
| GB201308843D0 (en) | 2013-03-14 | 2013-07-03 | Verenium Corp | Phytase formulation |
| EP2970869A4 (en) | 2013-03-14 | 2016-08-03 | Codexis Inc | REPRESSIBLE PROMOTER WITH LOW PHOSPHATE CONTENT |
| EP2970361B1 (en) * | 2013-03-15 | 2023-02-15 | Gen9, Inc. | Compositions and methods for multiplex nucleic acids synthesis |
| EP2971000A4 (en) | 2013-03-15 | 2016-11-23 | Pioneer Hi Bred Int | PHI-4 POLYPEPTIDES AND METHOD FOR THEIR USE |
| US20160024516A1 (en) | 2013-03-15 | 2016-01-28 | Pioneer Hi-Bred International, Inc. | Modulation of ACC Deaminase Expression |
| DK2986722T3 (da) | 2013-04-18 | 2019-05-13 | Codexis Inc | Manipulerede phenylalaninammoniak-lyasepolypeptider |
| WO2014202089A2 (en) | 2013-06-18 | 2014-12-24 | Roskilde Universitet | Variants of anti-freeze polypeptides |
| KR20160033711A (ko) | 2013-07-25 | 2016-03-28 | 바스프 엔자임스 엘엘씨 | 피타아제 |
| CA2920339C (en) | 2013-08-16 | 2023-10-24 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| CA3223359A1 (en) | 2013-09-13 | 2015-03-19 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| DK3049973T3 (en) | 2013-09-27 | 2018-10-22 | Codexis Inc | AUTOMATED SCREENING OF ENZYM VARIENTS |
| US9822346B2 (en) | 2013-11-13 | 2017-11-21 | Codexis, Inc. | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
| EP3083936B1 (en) | 2013-12-19 | 2018-07-04 | Danisco US Inc. | Use of hydrophobins to increase gas transfer in aerobic fermentation processes |
| WO2015100277A2 (en) | 2013-12-23 | 2015-07-02 | University Of Rochester | Methods and compositions for ribosomal synthesis of macrocyclic peptides |
| NZ630311A (en) | 2013-12-27 | 2016-03-31 | Celgene Corp | Romidepsin formulations and uses thereof |
| JPWO2015108047A1 (ja) | 2014-01-15 | 2017-03-23 | 株式会社新日本科学 | 免疫誘導活性を有するキラル核酸アジュバンド及び免疫誘導活性剤 |
| US10149905B2 (en) | 2014-01-15 | 2018-12-11 | Shin Nippon Biomedical Laboratories, Ltd. | Chiral nucleic acid adjuvant having antitumor effect and antitumor agent |
| WO2015108046A1 (ja) | 2014-01-15 | 2015-07-23 | 株式会社新日本科学 | 抗アレルギー作用を有するキラル核酸アジュバンド及び抗アレルギー剤 |
| KR102423317B1 (ko) | 2014-01-16 | 2022-07-22 | 웨이브 라이프 사이언시스 리미티드 | 키랄 디자인 |
| US10227608B2 (en) | 2014-02-07 | 2019-03-12 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins from plants and methods for their use |
| EP3102684B1 (en) | 2014-02-07 | 2020-05-06 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| EP3126509A1 (en) | 2014-04-01 | 2017-02-08 | DuPont Nutrition Biosciences ApS | Method for increasing crude palm oil yields |
| CA2943432A1 (en) | 2014-04-16 | 2015-10-22 | Codexis, Inc. | Engineered tyrosine ammonia lyase |
| US9708587B2 (en) | 2014-07-09 | 2017-07-18 | Codexis, Inc. | P450-BM3 variants with improved activity |
| EP3778891A1 (en) | 2014-08-27 | 2021-02-17 | New England Biolabs, Inc. | Synthon formation |
| US9963687B2 (en) | 2014-08-27 | 2018-05-08 | New England Biolabs, Inc. | Fusion polymerase and method for using the same |
| WO2016033296A1 (en) | 2014-08-28 | 2016-03-03 | Codexis, Inc. | N-substituted 4-aminoquinazoline derivatives and methods of use |
| US10045987B2 (en) | 2014-08-28 | 2018-08-14 | Codexis, Inc. | Imidazoyl anilide derivatives and methods of use |
| MX381370B (es) | 2014-10-16 | 2025-03-12 | Corteva Agriscience Llc | Proteinas insecticidas y metodos de uso. |
| EP3224354B1 (en) | 2014-11-25 | 2021-01-13 | Codexis, Inc. | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
| WO2016183532A1 (en) | 2015-05-13 | 2016-11-17 | Synlogic, Inc. | Bacteria engineered to treat a disease or disorder |
| AU2015370125B2 (en) | 2014-12-22 | 2022-02-03 | Codexis, Inc. | Human alpha-galactosidase variants |
| AU2016207026B2 (en) | 2015-01-15 | 2021-12-02 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| EP3256577B1 (en) | 2015-02-10 | 2020-08-26 | Codexis, Inc. | Ketoreductase polypeptides for the synthesis of chiral compounds |
| CN107529763B (zh) | 2015-03-11 | 2021-08-20 | 先锋国际良种公司 | Pip-72的杀昆虫组合及使用方法 |
| EP3280817A2 (en) | 2015-04-07 | 2018-02-14 | Novozymes A/S | Methods for selecting enzymes having enhanced activity |
| CN107864658A (zh) | 2015-04-07 | 2018-03-30 | 诺维信公司 | 用于选择具有脂肪酶活性的酶的方法 |
| AU2016258091B2 (en) | 2015-05-07 | 2020-10-01 | Codexis, Inc. | Penicillin-G acylases |
| US9920102B2 (en) | 2015-05-15 | 2018-03-20 | Albert Einstein College Of Medicine, Inc. | Fusion tags for protein expression |
| CA2985198A1 (en) | 2015-05-19 | 2016-11-24 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| JP6867302B2 (ja) * | 2015-05-21 | 2021-04-28 | フル スペクトラム ジェネティクス, インコーポレイテッド | タンパク質の特徴を改善する方法 |
| WO2016210384A2 (en) | 2015-06-25 | 2016-12-29 | Synlogic, Inc. | Bacteria engineered to treat metabolic diseases |
| WO2017007547A1 (en) | 2015-07-07 | 2017-01-12 | Codexis, Inc. | Novel p450-bm3 variants with improved activity |
| CN109475096B (zh) | 2015-08-06 | 2022-08-23 | 先锋国际良种公司 | 植物来源的杀昆虫蛋白及其使用方法 |
| CA2997263C (en) | 2015-09-08 | 2022-10-04 | Theripion, Inc. | Apoa-1 fusion polypeptides and related compositions and methods |
| GB201516348D0 (en) * | 2015-09-15 | 2015-10-28 | Labgenius Ltd | Compositions and methods for polynucleotide assembly |
| JP6821598B2 (ja) | 2015-12-07 | 2021-01-27 | ザイマージェン インコーポレイテッド | Corynebacterium glutamicum由来のプロモーター |
| US11208649B2 (en) | 2015-12-07 | 2021-12-28 | Zymergen Inc. | HTP genomic engineering platform |
| US9988624B2 (en) | 2015-12-07 | 2018-06-05 | Zymergen Inc. | Microbial strain improvement by a HTP genomic engineering platform |
| US20180325119A1 (en) | 2015-12-18 | 2018-11-15 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| WO2017123592A1 (en) | 2016-01-11 | 2017-07-20 | Synlogic, Inc. | Bacteria engineered to treat disorders associated with bile salts |
| WO2017123676A1 (en) | 2016-01-11 | 2017-07-20 | Synlogic, Inc. | Recombinant bacteria engineered to treat diseases and disorders associated with amino acid metabolism and methods of use thereof |
| EP3402497A1 (en) | 2016-01-11 | 2018-11-21 | Synlogic Operating Company, Inc. | Bacteria engineered to treat metabolic diseases |
| WO2017139708A1 (en) | 2016-02-10 | 2017-08-17 | Synlogic, Inc. | Bacteria engineered to treat nonalcoholic steatohepatitis (nash) |
| EP3440207A1 (en) | 2016-04-07 | 2019-02-13 | Novozymes A/S | Methods for selecting enzymes having protease activity |
| EA201892293A1 (ru) | 2016-05-04 | 2019-04-30 | Пайонир Хай-Бред Интернэшнл, Инк. | Инсектицидные белки и способы их применения |
| WO2017193022A1 (en) | 2016-05-05 | 2017-11-09 | Codexis, Inc. | Penicillin-g acylases |
| CN109715817B (zh) | 2016-06-09 | 2022-12-09 | 科德克希思公司 | 用于化合物的羟基化的生物催化剂和方法 |
| WO2017218325A1 (en) | 2016-06-15 | 2017-12-21 | Codexis, Inc. | Engineered beta-glucosidases and glucosylation methods |
| US20190330641A1 (en) | 2016-06-17 | 2019-10-31 | National Hellenic Research Foundation | Systems for recombinant protein production |
| US10544411B2 (en) | 2016-06-30 | 2020-01-28 | Zymergen Inc. | Methods for generating a glucose permease library and uses thereof |
| US10544390B2 (en) | 2016-06-30 | 2020-01-28 | Zymergen Inc. | Methods for generating a bacterial hemoglobin library and uses thereof |
| EP3954202A1 (en) | 2016-07-01 | 2022-02-16 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins from plants and methods for their use |
| JP7316662B2 (ja) | 2016-08-26 | 2023-07-28 | コデクシス, インコーポレイテッド | 操作されたイミンレダクターゼ、ならびにケトン化合物およびアミン化合物の還元的アミノ化のための方法 |
| MX387927B (es) | 2016-11-01 | 2025-03-19 | Pioneer Hi Bred Int | Proteinas insecticidas y metodos para su uso. |
| WO2018136163A2 (en) | 2016-12-09 | 2018-07-26 | Theripion, Inc. | Tandem apoa-1 fusion polypeptides |
| US11174295B2 (en) | 2016-12-14 | 2021-11-16 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| EP3558004A1 (en) | 2016-12-22 | 2019-10-30 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| CA3048475A1 (en) | 2017-01-05 | 2018-07-12 | Codexis, Inc. | Penicillin-g acylases |
| EP3882354A3 (en) | 2017-02-03 | 2021-12-15 | Codexis, Inc. | Engineered glycosyltransferases and steviol glycoside glucosylation methods |
| MX2019009371A (es) | 2017-02-08 | 2019-09-23 | Pionner Hi Bred Int Inc | Combinaciones insecticidas de proteinas insecticidas derivadas de plantas y metodos para su uso. |
| BR112019016634A2 (pt) | 2017-02-13 | 2020-04-07 | Codexis Inc | polipeptídeos, sequência de polinucleotídeos modificados por engenharia, vetor de expressão, célula hospedeira, métodos para produzir um polipeptídeo de fenilalanina amônia liase modificado por engenharia em uma célula hospedeira e para tratar e/ou prevenir os sintomas de fenilcetonúria em um indivíduo, composição, e, uso |
| WO2018200214A2 (en) | 2017-04-27 | 2018-11-01 | Codexis, Inc. | Ketoreductase polypeptides and polynucleotides |
| WO2018208665A1 (en) | 2017-05-08 | 2018-11-15 | Codexis, Inc. | Engineered ligase variants |
| WO2018209301A1 (en) | 2017-05-11 | 2018-11-15 | Cytodyn Inc. | Methods for treating or preventing graft-versus-host disease involving the administration of anti-ccr5 receptor agents |
| WO2018208882A1 (en) | 2017-05-11 | 2018-11-15 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| WO2018226880A1 (en) * | 2017-06-06 | 2018-12-13 | Zymergen Inc. | A htp genomic engineering platform for improving escherichia coli |
| JP7350659B2 (ja) * | 2017-06-06 | 2023-09-26 | ザイマージェン インコーポレイテッド | Saccharopolyspora spinosaの改良のためのハイスループット(HTP)ゲノム操作プラットフォーム |
| WO2018231462A1 (en) | 2017-06-14 | 2018-12-20 | Codexis, Inc. | Engineered transaminase polypeptides for industrial biocatalysis |
| US11643642B2 (en) | 2017-06-27 | 2023-05-09 | Codexis, Inc. | Penicillin-g acylases |
| US10793841B2 (en) | 2017-06-30 | 2020-10-06 | Codexis, Inc. | T7 RNA polymerase variants |
| JP2020530267A (ja) | 2017-06-30 | 2020-10-22 | コデクシス, インコーポレイテッド | T7 rnaポリメラーゼバリアント |
| WO2019040335A1 (en) | 2017-08-19 | 2019-02-28 | University Of Rochester | MICHELOLID DERIVATIVES, PREPARATION METHODS AND THEIR USE AS ANTICANCER AND ANTI-INFLAMMATORY AGENTS |
| US11319531B2 (en) | 2017-11-07 | 2022-05-03 | Codexis, Inc. | Transglutaminase variants |
| SG11202004185PA (en) | 2017-12-13 | 2020-06-29 | Codexis Inc | Carboxyesterase polypeptides for amide coupling |
| AU2019234566B2 (en) | 2018-03-14 | 2024-09-26 | Hexima Limited | Insecticidal proteins from plants and methods for their use |
| EP3764796B1 (en) | 2018-03-14 | 2025-12-03 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins from plants and methods for their use |
| WO2019222226A2 (en) | 2018-05-17 | 2019-11-21 | Bp Corporation North America Inc. | Production of 2-keto-3-deoxy-d-gluconic acid in filamentous fungi |
| EP3807409A4 (en) | 2018-06-12 | 2022-08-03 | Codexis, Inc. | Engineered tyrosine ammonia lyase |
| WO2020014046A1 (en) | 2018-07-09 | 2020-01-16 | Codexis, Inc. | Engineered phosphopentomutase variant enzymes |
| KR20210031926A (ko) | 2018-07-09 | 2021-03-23 | 코덱시스, 인코포레이티드 | 조작된 퓨린 뉴클레오사이드 포스포릴라제 변이체 효소 |
| MX2021000328A (es) | 2018-07-09 | 2021-03-25 | Codexis Inc | Enzimas de variantes de galactosa oxidasa modificadas geneticamente. |
| CA3103819A1 (en) | 2018-07-09 | 2020-01-16 | Codexis, Inc. | Engineered pantothenate kinase variant enzymes |
| SG11202012107RA (en) | 2018-07-09 | 2021-01-28 | Codexis Inc | Engineered deoxyribose-phosphate aldolases |
| EP3820833A4 (en) | 2018-07-12 | 2022-08-03 | Codexis, Inc. | MODIFIED AMMONIA-LYASE PHENYLALANINE POLYPEPTIDES |
| BR112021001661A8 (pt) | 2018-07-30 | 2022-08-09 | Codexis Inc | Glicosiltransferase modificada, polinucleotídeo modificado, vetor, célula hospedeira, métodos para produzir pelo menos uma glicosiltransferase modificada, para produzir pelo menos uma variante de sacarose sintase, para glicosilação de um substrato, para produzir rebaudiosídeo m, rebaudiosídeo a e/ou rebaudiosídeo i e rebaudiosídeo d, composição, sacarose sintase modificada, pelo menos um rebaudiosídeo, rebaudiosídeo m, rebaudiosídeo a, rebaudiosídeo i, e, rebaudiosídeo d. |
| CN112969792A (zh) | 2018-09-07 | 2021-06-15 | 巴斯夫植物科学有限公司 | 用于在植物中产生高水平pufa的改进方法 |
| EP3847264A1 (en) | 2018-09-07 | 2021-07-14 | Basf Plant Science Company GmbH | Improved method for the production of high levels of pufa in plants |
| AU2019334671A1 (en) | 2018-09-07 | 2021-03-25 | Basf Plant Science Company Gmbh | Improved method for the production of high levels of PUFA in plants |
| SG11202103639SA (en) | 2018-10-29 | 2021-05-28 | Codexis Inc | Engineered dna polymerase variants |
| CA3122524A1 (en) | 2018-12-14 | 2020-06-18 | Codexis, Inc. | Engineered tyrosine ammonia lyase |
| CA3123598A1 (en) | 2018-12-20 | 2020-06-25 | Codexis, Inc. | Human alpha-galactosidase variants |
| EP3906312A4 (en) | 2019-01-02 | 2022-09-28 | Intima Bioscience, Inc. | MODIFIED ADENO-ASSOCIATED VIRAL VECTORS FOR USE IN GENETIC ENGINEERING |
| WO2020150125A1 (en) | 2019-01-15 | 2020-07-23 | Codexis, Inc. | Engineered transaminase polypeptides |
| CN113874392B (zh) | 2019-03-28 | 2025-10-21 | 丹尼斯科美国公司 | 工程化抗体 |
| CN114096662B (zh) | 2019-05-01 | 2025-04-15 | 科德克希思公司 | 工程化葡萄糖脱氢酶和用于酮和胺化合物的还原胺化的方法 |
| US12215368B2 (en) | 2019-05-01 | 2025-02-04 | Codexis, Inc. | Engineered imine reductases and methods for the reductive amination of ketone and amine compounds |
| AU2020299358A1 (en) | 2019-07-02 | 2021-12-23 | Codexis, Inc. | Engineered acetate kinase variant enzymes |
| CA3142636A1 (en) | 2019-07-02 | 2021-01-07 | Codexis, Inc. | Engineered sucrose phosphorylase variant enzymes |
| BR112022001037A2 (pt) | 2019-08-02 | 2022-06-07 | Cytodyn Inc | Métodos para tratamento ou prevenção de cânceres envolvendo a administração de agentes receptores anti-ccr5 |
| AU2020336468A1 (en) | 2019-08-30 | 2022-03-03 | Societe Des Produits Nestle S.A. | Engineered lipase variants |
| WO2021050348A1 (en) | 2019-09-12 | 2021-03-18 | Codexis, Inc. | Peroxidase activity towards 10-acetyl-3,7-dihydroxyphenoxazine |
| JP7720098B2 (ja) | 2019-11-26 | 2025-08-07 | コデクシス, インコーポレイテッド | 化合物のヒドロキシル化のための生体触媒および方法 |
| EP4077679A4 (en) | 2019-12-20 | 2024-04-24 | Codexis, Inc. | MODIFIED ACID ALPHA-GLUCOSIDASE VARIANTS |
| KR20220119408A (ko) | 2019-12-20 | 2022-08-29 | 바스프 에스이 | 터펜의 독성 감소 및 미생물에서 생산 잠재성 증가 |
| EP4087932A4 (en) | 2020-01-10 | 2024-01-17 | The Regents of the University of California | Biosynthetic platform for the production of olivetolic avid and analogues of olivetolic acid |
| KR20220137057A (ko) | 2020-02-04 | 2022-10-11 | 코덱시스, 인코포레이티드 | 조작된 류신 데카르복실라제 |
| US11045546B1 (en) | 2020-03-30 | 2021-06-29 | Cytodyn Inc. | Methods of treating coronavirus infection |
| JP2023521772A (ja) | 2020-04-10 | 2023-05-25 | コデクシス, インコーポレイテッド | 操作されたトランスアミナーゼポリペプチド |
| US11499166B2 (en) | 2020-04-27 | 2022-11-15 | 4D Molecular Therapeutics Inc. | Adeno-associated variants, formulations and methods for pulmonary delivery |
| WO2021245064A1 (en) | 2020-06-04 | 2021-12-09 | Isobionics B.V. | Synthetic santalene synthases |
| CA3186978A1 (en) | 2020-07-14 | 2022-01-20 | Pioneer Hi-Bred International, Inc. | Insecticidal proteins and methods for their use |
| CA3191900A1 (en) | 2020-08-28 | 2022-03-03 | Codexis, Inc. | Engineered amylase variants |
| BR112023003606A2 (pt) | 2020-08-28 | 2023-03-28 | Codexis Inc | Protease recombinante, composição, sequência polinucleotídica recombinante, vetor de expressão, célula hospedeira, métodos para produzir uma protease recombinante e para tratar e/ou prevenir os sintomas de insuficiência pancreática, e, uso |
| CA3201757A1 (en) | 2020-12-11 | 2022-06-16 | Mathias Schuetz | Recombinant acyl activating enzyme (aae) genes for enhanced biosynthesis of cannabinoids and cannabinoid precursors |
| WO2022133289A2 (en) | 2020-12-18 | 2022-06-23 | Codexis, Inc. | Engineered uridine phosphorylase variant enzymes |
| EP4015626A1 (en) | 2020-12-18 | 2022-06-22 | Isobionics B.V. | Enzymes and methods for fermentative production of monoterpene esters |
| CA3207134A1 (en) | 2021-02-19 | 2022-08-25 | Jeffrey A. Ledbetter | Dnase fusion polypeptides and related compositions and methods |
| EP4314262A1 (en) | 2021-04-02 | 2024-02-07 | Codexis, Inc. | Engineered guanylate kinase variant enzymes |
| EP4314261A1 (en) | 2021-04-02 | 2024-02-07 | Codexis, Inc. | Engineered acetate kinase variant enzymes |
| EP4314264A1 (en) | 2021-04-02 | 2024-02-07 | Codexis, Inc. | Engineered cyclic gmp-amp synthase (cgas) variant enzymes |
| CN117120600A (zh) | 2021-04-02 | 2023-11-24 | 科德克希思公司 | 工程化腺苷酸激酶变体酶 |
| JP2024519906A (ja) | 2021-05-21 | 2024-05-21 | コデクシス, インコーポレイテッド | 操作されたメチオニンガンマリアーゼバリアント |
| CA3227215A1 (en) | 2021-07-30 | 2023-02-02 | Trish Choudhary | Recombinant prenyltransferase polypeptides engineered for enhanced biosynthesis of cannabinoids |
| WO2023012111A2 (en) | 2021-08-02 | 2023-02-09 | Basf Se | Novel production of aroma compounds with ionylideneethane synthases |
| WO2023023621A1 (en) | 2021-08-19 | 2023-02-23 | Willow Biosciences, Inc. | Recombinant olivetolic acid cyclase polypeptides engineered for enhanced biosynthesis of cannabinoids |
| JP2024539636A (ja) | 2021-10-15 | 2024-10-29 | コデクシス, インコーポレイテッド | 操作されたdnaポリメラーゼバリアント |
| WO2023069921A1 (en) | 2021-10-19 | 2023-04-27 | Epimeron Usa, Inc. | Recombinant thca synthase polypeptides engineered for enhanced biosynthesis of cannabinoids |
| EP4426827A2 (en) | 2021-11-01 | 2024-09-11 | Syntis Bio, Inc. | Engineered leucine decarboxylases |
| CN114015672B (zh) * | 2021-12-06 | 2022-05-31 | 江南大学 | 一种Pfu DNA聚合酶 |
| EP4490202A1 (en) | 2022-03-11 | 2025-01-15 | University of Rochester | Cyclopeptibodies and uses thereof |
| WO2023245171A1 (en) | 2022-06-17 | 2023-12-21 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof |
| WO2023245168A1 (en) | 2022-06-17 | 2023-12-21 | Synlogic Operating Company, Inc. | Bacteria engineered to treat diseases associated with bile acid metabolism and methods of use thereof |
| WO2023250478A1 (en) | 2022-06-23 | 2023-12-28 | Synlogic Operating Company, Inc. | Recombinant bacteria engineered to treat diseases associated with methionine metabolism and methods of use thereof |
| WO2024040020A1 (en) | 2022-08-15 | 2024-02-22 | Absci Corporation | Quantitative affinity activity specific cell enrichment |
| WO2024259220A1 (en) | 2023-06-15 | 2024-12-19 | Theripion, Inc. | Pon3 and evolved pon1 fusion polypeptides |
| WO2025144700A1 (en) | 2023-12-27 | 2025-07-03 | Absci Corporation | Nanobody library screening using bacterial surface display |
| WO2025199112A2 (en) | 2024-03-19 | 2025-09-25 | General Biological Corporation | Bio-based production of succinic acid using vibrio natriegens |
| WO2025224232A1 (en) * | 2024-04-25 | 2025-10-30 | Danmarks Tekniske Universitet | Pcr leaping and applications thereof |
| WO2025235589A1 (en) | 2024-05-08 | 2025-11-13 | Codexis, Inc. | Dna polymerase variants |
Family Cites Families (119)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4994379A (en) | 1983-03-09 | 1991-02-19 | Cetus Corporation | Modified signal peptides |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US5422266A (en) * | 1984-12-31 | 1995-06-06 | University Of Georgia Research Foundation, Inc. | Recombinant DNA vectors capable of expressing apoaequorin |
| US4683202A (en) * | 1985-03-28 | 1987-07-28 | Cetus Corporation | Process for amplifying nucleic acid sequences |
| US5176995A (en) * | 1985-03-28 | 1993-01-05 | Hoffmann-La Roche Inc. | Detection of viruses by amplification and hybridization |
| US4965188A (en) * | 1986-08-22 | 1990-10-23 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences using a thermostable enzyme |
| US6492107B1 (en) * | 1986-11-20 | 2002-12-10 | Stuart Kauffman | Process for obtaining DNA, RNA, peptides, polypeptides, or protein, by recombinant DNA technique |
| DE229046T1 (de) | 1985-03-30 | 1987-12-17 | Marc Genf/Geneve Ballivet | Verfahren zum erhalten von dns, rns, peptiden, polypeptiden oder proteinen durch dns-rekombinant-verfahren. |
| US4959312A (en) * | 1985-05-31 | 1990-09-25 | The University Of Tennessee Research Corporation | Full spectrum mutagenesis |
| DE3688920D1 (de) * | 1985-07-03 | 1993-09-30 | Genencor Int | Hybride Polypeptide und Verfahren zu deren Herstellung. |
| US5866363A (en) | 1985-08-28 | 1999-02-02 | Pieczenik; George | Method and means for sorting and identifying biological information |
| US4800159A (en) * | 1986-02-07 | 1989-01-24 | Cetus Corporation | Process for amplifying, detecting, and/or cloning nucleic acid sequences |
| DK311186D0 (da) * | 1986-06-30 | 1986-06-30 | Novo Industri As | Enzymer |
| US5824469A (en) | 1986-07-17 | 1998-10-20 | University Of Washington | Method for producing novel DNA sequences with biological activity |
| US4994368A (en) * | 1987-07-23 | 1991-02-19 | Syntex (U.S.A.) Inc. | Amplification method for polynucleotide assays |
| FR2641793B1 (fr) | 1988-12-26 | 1993-10-01 | Setratech | Procede de recombinaison in vivo de sequences d'adn presentant des mesappariements de bases |
| DD282028A5 (de) | 1989-02-16 | 1990-08-29 | Akad Wissenschaften Ddr | Verfahren zur herstellung einer thermostabilen, hybriden bacillus-beta-1,3-1,4-glukanase |
| US5106727A (en) | 1989-04-27 | 1992-04-21 | Life Technologies, Inc. | Amplification of nucleic acid sequences using oligonucleotides of random sequences as primers |
| US5043272A (en) * | 1989-04-27 | 1991-08-27 | Life Technologies, Incorporated | Amplification of nucleic acid sequences using oligonucleotides of random sequence as primers |
| US5556750A (en) * | 1989-05-12 | 1996-09-17 | Duke University | Methods and kits for fractionating a population of DNA molecules based on the presence or absence of a base-pair mismatch utilizing mismatch repair systems |
| CA2016841C (en) | 1989-05-16 | 1999-09-21 | William D. Huse | A method for producing polymers having a preselected activity |
| CA2016842A1 (en) * | 1989-05-16 | 1990-11-16 | Richard A. Lerner | Method for tapping the immunological repertoire |
| IT1231157B (it) * | 1989-07-20 | 1991-11-19 | Crc Ricerca Chim | Nuovi geni ibridi funzionali di bacillus thuringiensis ottenuti mediante ricombinazione in vivo. |
| US5574205A (en) | 1989-07-25 | 1996-11-12 | Cell Genesys | Homologous recombination for universal donor cells and chimeric mammalian hosts |
| US5023171A (en) * | 1989-08-10 | 1991-06-11 | Mayo Foundation For Medical Education And Research | Method for gene splicing by overlap extension using the polymerase chain reaction |
| WO1991006570A1 (en) * | 1989-10-25 | 1991-05-16 | The University Of Melbourne | HYBRID Fc RECEPTOR MOLECULES |
| US5071743A (en) * | 1989-10-27 | 1991-12-10 | Her Majesty The Queen In Right Of Canada, As Represented By The National Research Council Of Canada | Process for conducting site-directed mutagenesis |
| DE3936258C1 (enExample) * | 1989-10-31 | 1991-04-25 | Max-Planck-Gesellschaft Zur Foerderung Der Wissenschaften Ev, 3400 Goettingen, De | |
| WO1991007506A1 (en) * | 1989-11-08 | 1991-05-30 | The United States Of America, Represented By The Secretary, United States Department Of Commerce | A method of synthesizing double-stranded dna molecules |
| US5242937A (en) | 1990-03-19 | 1993-09-07 | Research Corporation Technologies, Inc. | Topically active ocular thiadiazole sulfonamide carbonic anhydrase inhibitors |
| EP0527809B1 (en) * | 1990-04-05 | 1995-08-16 | CREA, Roberto | Walk-through mutagenesis |
| EP0528881A4 (en) * | 1990-04-24 | 1993-05-26 | Stratagene | Methods for phenotype creation from multiple gene populations |
| US5877402A (en) * | 1990-05-01 | 1999-03-02 | Rutgers, The State University Of New Jersey | DNA constructs and methods for stably transforming plastids of multicellular plants and expressing recombinant proteins therein |
| US5851813A (en) * | 1990-07-12 | 1998-12-22 | President And Fellows Of Harvard College | Primate lentivirus antigenic compositions |
| JP3392863B2 (ja) * | 1990-07-24 | 2003-03-31 | エフ.ホフマン ― ラ ロシュ アーゲー | 修飾核酸塩基を使用するインビトロ核酸増幅における非特異的増幅の低減 |
| US5264563A (en) | 1990-08-24 | 1993-11-23 | Ixsys Inc. | Process for synthesizing oligonucleotides with random codons |
| DE69130647T2 (de) | 1990-08-24 | 1999-05-06 | Ixsys, Inc., San Diego, Calif. | Verfahren zur herstellung von oligonukleotiden mit regellosen codonen |
| IL99553A0 (en) | 1990-09-28 | 1992-08-18 | Ixsys Inc | Compositions containing oligonucleotides linked to expression elements,a kit for the preparation of vectors useful for the expression of a diverse population of random peptides and methods utilizing the same |
| US5770434A (en) | 1990-09-28 | 1998-06-23 | Ixsys Incorporated | Soluble peptides having constrained, secondary conformation in solution and method of making same |
| US5698426A (en) | 1990-09-28 | 1997-12-16 | Ixsys, Incorporated | Surface expression libraries of heteromeric receptors |
| US5871974A (en) | 1990-09-28 | 1999-02-16 | Ixsys Inc. | Surface expression libraries of heteromeric receptors |
| US5858725A (en) * | 1990-10-10 | 1999-01-12 | Glaxo Wellcome Inc. | Preparation of chimaeric antibodies using the recombinant PCR strategy |
| US5187083A (en) * | 1990-11-13 | 1993-02-16 | Specialty Laboratories, Inc. | Rapid purification of DNA |
| US5234824A (en) * | 1990-11-13 | 1993-08-10 | Specialty Laboratories, Inc. | Rapid purification of DNA |
| US5489523A (en) * | 1990-12-03 | 1996-02-06 | Stratagene | Exonuclease-deficient thermostable Pyrococcus furiosus DNA polymerase I |
| EP0563296B1 (en) | 1990-12-20 | 1999-03-17 | Ixsys, Inc. | Optimization of binding proteins |
| US5098437A (en) | 1991-02-13 | 1992-03-24 | Pfizer Hospital Products Group, Inc. | Acetabular cup positioning insert |
| DE4112440C1 (enExample) | 1991-04-16 | 1992-10-22 | Diagen Institut Fuer Molekularbiologische Diagnostik Gmbh, 4000 Duesseldorf, De | |
| US5795747A (en) * | 1991-04-16 | 1998-08-18 | Evotec Biosystems Gmbh | Process for manufacturing new biopolymers |
| US5512463A (en) * | 1991-04-26 | 1996-04-30 | Eli Lilly And Company | Enzymatic inverse polymerase chain reaction library mutagenesis |
| US5514568A (en) * | 1991-04-26 | 1996-05-07 | Eli Lilly And Company | Enzymatic inverse polymerase chain reaction |
| ES2091976T3 (es) | 1991-06-20 | 1996-11-16 | Hoffmann La Roche | Metodos perfeccionados para la amplificacion del acido nucleico. |
| WO1993000103A1 (en) * | 1991-06-21 | 1993-01-07 | The Wistar Institute Of Anatomy And Biology | Chimeric envelope proteins for viral targeting |
| JP3442774B2 (ja) * | 1991-07-01 | 2003-09-02 | バーレックス ラボラトリーズ,インコーポレイティド | 新規な突然変異誘発法および組成物 |
| US6071889A (en) * | 1991-07-08 | 2000-06-06 | Neurospheres Holdings Ltd. | In vivo genetic modification of growth factor-responsive neural precursor cells |
| US5223408A (en) * | 1991-07-11 | 1993-06-29 | Genentech, Inc. | Method for making variant secreted proteins with altered properties |
| GB9115364D0 (en) * | 1991-07-16 | 1991-08-28 | Wellcome Found | Antibody |
| US5279952A (en) * | 1991-08-09 | 1994-01-18 | Board Of Regents, The University Of Texas System | PCR-based strategy of constructing chimeric DNA molecules |
| DE69229477T2 (de) * | 1991-09-23 | 1999-12-09 | Cambridge Antibody Technology Ltd., Melbourn | Methoden zur Herstellung humanisierter Antikörper |
| GB9125979D0 (en) * | 1991-12-06 | 1992-02-05 | Wellcome Found | Antibody |
| CA2127126A1 (en) * | 1992-01-30 | 1993-08-05 | Helen M. Wilks | Chiral synthesis with modified enzymes |
| US5773267A (en) * | 1992-02-07 | 1998-06-30 | Albert Einstein College Of Medicine Of Yeshiva University, A Division Of Yeshiva University | D29 shuttle phasmids and uses thereof |
| GB9202796D0 (en) * | 1992-02-11 | 1992-03-25 | Wellcome Found | Antiviral antibody |
| US5843643A (en) * | 1992-02-21 | 1998-12-01 | Ratner; Paul L. | Site-specific transfection of eukaryotic cells using polypeptide-linked recombinant nucleic acid |
| WO1993018141A1 (en) * | 1992-03-02 | 1993-09-16 | Biogen, Inc. | Thrombin receptor antagonists |
| ATE280219T1 (de) | 1992-03-16 | 2004-11-15 | Jacob Nathaniel Wohlstadter | Mutagenese und selektionsmethoden in den selben wirtszellen |
| US5316935A (en) * | 1992-04-06 | 1994-05-31 | California Institute Of Technology | Subtilisin variants suitable for hydrolysis and synthesis in organic media |
| CA2115346A1 (en) * | 1992-06-15 | 1993-12-23 | John E. Shively | Chimeric anti-cea antibody |
| JP2979178B2 (ja) * | 1992-07-10 | 1999-11-15 | エナジー バイオシステムズ コーポレーション | 脱硫用生物触媒をコードする組換えdna |
| US6107062A (en) * | 1992-07-30 | 2000-08-22 | Inpax, Inc. | Antisense viruses and antisense-ribozyme viruses |
| FR2694754B1 (fr) * | 1992-08-12 | 1994-09-16 | Bio Merieux | Fragments d'ADN de mycobactéries, amorces d'amplification, sondes d'hybridation, réactifs et procédé de détection de détection de mycobactéries. |
| EP0627932B1 (en) * | 1992-11-04 | 2002-05-08 | City Of Hope | Antibody construct |
| EP0675953B1 (en) | 1992-11-10 | 2009-01-28 | Applied Molecular Evolution, Inc. | Soluble peptides having constrained, secondary conformation in solution and method of making same |
| US5360728A (en) * | 1992-12-01 | 1994-11-01 | Woods Hole Oceanographic Institution (W.H.O.I.) | Modified apoaequorin having increased bioluminescent activity |
| DK0672142T3 (da) * | 1992-12-04 | 2001-06-18 | Medical Res Council | Multivalente og multispecifikke bindingsproteiner samt fremstilling og anvendelse af disse |
| US5380530A (en) | 1992-12-29 | 1995-01-10 | Whitehill Oral Technologies | Oral care composition coated gum |
| IT1264712B1 (it) * | 1993-07-13 | 1996-10-04 | Eniricerche Spa | Metodo di sintesi biologica di peptidi |
| US5498531A (en) | 1993-09-10 | 1996-03-12 | President And Fellows Of Harvard College | Intron-mediated recombinant techniques and reagents |
| US5556772A (en) * | 1993-12-08 | 1996-09-17 | Stratagene | Polymerase compositions and uses thereof |
| DE4343591A1 (de) * | 1993-12-21 | 1995-06-22 | Evotec Biosystems Gmbh | Verfahren zum evolutiven Design und Synthese funktionaler Polymere auf der Basis von Formenelementen und Formencodes |
| US5605793A (en) | 1994-02-17 | 1997-02-25 | Affymax Technologies N.V. | Methods for in vitro recombination |
| US5834252A (en) * | 1995-04-18 | 1998-11-10 | Glaxo Group Limited | End-complementary polymerase reaction |
| US5837458A (en) * | 1994-02-17 | 1998-11-17 | Maxygen, Inc. | Methods and compositions for cellular and metabolic engineering |
| US6117679A (en) * | 1994-02-17 | 2000-09-12 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US6165793A (en) | 1996-03-25 | 2000-12-26 | Maxygen, Inc. | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
| US5928905A (en) | 1995-04-18 | 1999-07-27 | Glaxo Group Limited | End-complementary polymerase reaction |
| US5521077A (en) * | 1994-04-28 | 1996-05-28 | The Leland Stanford Junior University | Method of generating multiple protein variants and populations of protein variants prepared thereby |
| US5514588A (en) | 1994-12-13 | 1996-05-07 | Exxon Research And Engineering Company | Surfactant-nutrients for bioremediation of hydrocarbon contaminated soils and water |
| US5629179A (en) * | 1995-03-17 | 1997-05-13 | Novagen, Inc. | Method and kit for making CDNA library |
| DE19612631A1 (de) | 1995-03-31 | 1996-10-02 | Mazda Motor | Multiplexdatenübermittlungssystem |
| CA2219136A1 (en) * | 1995-04-24 | 1996-10-31 | Chromaxome Corp. | Methods for generating and screening novel metabolic pathways |
| US6057103A (en) | 1995-07-18 | 2000-05-02 | Diversa Corporation | Screening for novel bioactivities |
| US6168919B1 (en) | 1996-07-17 | 2001-01-02 | Diversa Corporation | Screening methods for enzymes and enzyme kits |
| US6030779A (en) | 1995-07-18 | 2000-02-29 | Diversa Corporation | Screening for novel bioactivities |
| US5958672A (en) * | 1995-07-18 | 1999-09-28 | Diversa Corporation | Protein activity screening of clones having DNA from uncultivated microorganisms |
| US6004788A (en) | 1995-07-18 | 1999-12-21 | Diversa Corporation | Enzyme kits and libraries |
| DE69620766T2 (de) * | 1995-08-11 | 2004-11-18 | Novozymes A/S | Verfahren zur herstellung von polypeptidabkömmlingen |
| US5962258A (en) | 1995-08-23 | 1999-10-05 | Diversa Corporation | Carboxymethyl cellulase fromthermotoga maritima |
| US6051409A (en) * | 1995-09-25 | 2000-04-18 | Novartis Finance Corporation | Method for achieving integration of exogenous DNA delivered by non-biological means to plant cells |
| US5756316A (en) | 1995-11-02 | 1998-05-26 | Genencor International, Inc. | Molecular cloning by multimerization of plasmids |
| US6238884B1 (en) | 1995-12-07 | 2001-05-29 | Diversa Corporation | End selection in directed evolution |
| US5830696A (en) | 1996-12-05 | 1998-11-03 | Diversa Corporation | Directed evolution of thermophilic enzymes |
| US5965408A (en) * | 1996-07-09 | 1999-10-12 | Diversa Corporation | Method of DNA reassembly by interrupting synthesis |
| US5939250A (en) | 1995-12-07 | 1999-08-17 | Diversa Corporation | Production of enzymes having desired activities by mutagenesis |
| US20030215798A1 (en) | 1997-06-16 | 2003-11-20 | Diversa Corporation | High throughput fluorescence-based screening for novel enzymes |
| US6171820B1 (en) | 1995-12-07 | 2001-01-09 | Diversa Corporation | Saturation mutagenesis in directed evolution |
| JP2000502568A (ja) * | 1996-01-10 | 2000-03-07 | ノボ ノルディスク アクティーゼルスカブ | 細胞内での突然変異ライブラリーの in vivo製造のための方法 |
| US6096548A (en) * | 1996-03-25 | 2000-08-01 | Maxygen, Inc. | Method for directing evolution of a virus |
| US5783431A (en) * | 1996-04-24 | 1998-07-21 | Chromaxome Corporation | Methods for generating and screening novel metabolic pathways |
| US5763239A (en) | 1996-06-18 | 1998-06-09 | Diversa Corporation | Production and use of normalized DNA libraries |
| US6093873A (en) | 1996-08-19 | 2000-07-25 | Institut National De La Sante Et De La Recherche Medicale | Genetically engineered mice containing alterations in the gene encoding RXR |
| WO1998028416A1 (en) * | 1996-12-20 | 1998-07-02 | Novo Nordisk A/S | In vivo recombination |
| KR20000076363A (ko) * | 1997-03-18 | 2000-12-26 | 한센 핀 베네드, 안네 제헤르, 웨이콥 마리안느 | Dna 라이브러리를 제조하기 위한 시험관내 방법 |
| JP4263248B2 (ja) * | 1997-03-18 | 2009-05-13 | ノボザイムス アクティーゼルスカブ | Dnaのシャッフリングによるライブラリーの作成方法 |
| AU738461B2 (en) * | 1997-03-18 | 2001-09-20 | Novozymes A/S | Shuffling of heterologous DNA sequences |
| US5948653A (en) | 1997-03-21 | 1999-09-07 | Pati; Sushma | Sequence alterations using homologous recombination |
| US6153410A (en) * | 1997-03-25 | 2000-11-28 | California Institute Of Technology | Recombination of polynucleotide sequences using random or defined primers |
| US6051049A (en) | 1997-05-29 | 2000-04-18 | Exothermic Distribution Corporation | Utilization of strontium aluminate in steelmaking |
| US6087341A (en) | 1998-02-12 | 2000-07-11 | The Board Of Trustees Of The Leland Standford Junior University | Introduction of nucleic acid into skin cells by topical application |
-
1996
- 1996-03-25 US US08/621,859 patent/US6117679A/en not_active Expired - Lifetime
- 1996-12-02 EP EP96940934A patent/EP0876509B2/en not_active Expired - Lifetime
- 1996-12-02 DE DE69615411T patent/DE69615411T2/de not_active Expired - Fee Related
- 1996-12-02 DK DK96940934.1T patent/DK0876509T4/da active
- 1996-12-02 AT AT98122014T patent/ATE205878T1/de not_active IP Right Cessation
- 1996-12-02 DE DE0876509T patent/DE876509T1/de active Pending
- 1996-12-02 AU AU10873/97A patent/AU713952B2/en not_active Ceased
- 1996-12-02 DK DK98122014T patent/DK0911396T3/da active
- 1996-12-02 WO PCT/US1996/019256 patent/WO1997020078A1/en not_active Ceased
- 1996-12-02 EP EP01103198A patent/EP1103606A3/en not_active Withdrawn
- 1996-12-02 CA CA002239099A patent/CA2239099C/en not_active Expired - Fee Related
- 1996-12-02 AT AT96940934T patent/ATE205877T1/de active
- 1996-12-02 ES ES98122014T patent/ES2165124T3/es not_active Expired - Lifetime
- 1996-12-02 DE DE0911396T patent/DE911396T1/de active Pending
- 1996-12-02 ES ES96940934T patent/ES2164929T5/es not_active Expired - Lifetime
- 1996-12-02 EP EP98122014A patent/EP0911396B1/en not_active Revoked
- 1996-12-02 EP EP01113250A patent/EP1138763A3/en not_active Withdrawn
- 1996-12-02 DE DE69615406T patent/DE69615406T3/de not_active Expired - Lifetime
- 1996-12-02 JP JP52074497A patent/JP4015193B2/ja not_active Expired - Fee Related
- 1996-12-02 IL IL12467596A patent/IL124675A0/xx unknown
-
1998
- 1998-06-17 US US09/099,015 patent/US6180406B1/en not_active Expired - Lifetime
- 1998-10-02 US US09/165,060 patent/US6291242B1/en not_active Expired - Lifetime
-
1999
- 1999-01-29 US US09/240,307 patent/US6573098B1/en not_active Expired - Fee Related
- 1999-01-29 US US09/240,734 patent/US6413774B1/en not_active Expired - Fee Related
- 1999-01-29 US US09/240,310 patent/US6323030B1/en not_active Expired - Lifetime
- 1999-09-21 JP JP11267847A patent/JP2000308490A/ja active Pending
-
2000
- 2000-06-08 US US09/590,778 patent/US6344356B1/en not_active Expired - Lifetime
- 2000-06-08 US US09/590,774 patent/US6372497B1/en not_active Expired - Fee Related
-
2004
- 2004-03-30 JP JP2004101193A patent/JP2004187694A/ja not_active Withdrawn
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69615411T2 (de) | Verfahren zur Herstellung von Polynucleotiden mit erwünschten Eigenschaften mittels wiederholter Selektion und Rekombination | |
| DE69525084T2 (de) | DNA-Mutagenese durch Zufallsfragmentierung und Wiederaufbau | |
| US7868138B2 (en) | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination | |
| US6995017B1 (en) | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination | |
| US6395547B1 (en) | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination | |
| US6506602B1 (en) | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination | |
| KR100491810B1 (ko) | 무작위단편화및재조립에의한dna돌연변이유발방법 | |
| AU744681B2 (en) | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination | |
| AU2005202165B2 (en) | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination | |
| AU1197202A (en) | Methods for generating polynucleotides having desired characteristics by iterative selection and recombination |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8363 | Opposition against the patent | ||
| 8339 | Ceased/non-payment of the annual fee |